$PMT
PennyMac Mortgage Investment Trust Stock $pmt

$pmt Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-K Financial Statement

#000156459018004038 Filed on March 01, 2018

Income Statement

Concept	2017 Q4	2017 Q3	2017 Q2
Revenue	$93.70M	$75.80M	$83.96M
YoY Change	35.94%	-26.64%	76.32%
Cost Of Revenue	$74.90M	$84.30M	$80.60M
YoY Change	-19.11%	-6.23%	-1.23%
Gross Profit	$54.30M	$31.80M	$41.80M
YoY Change	215.7%	-40.89%	1507.69%
Gross Profit Margin	57.95%	41.95%	49.79%
Selling, General & Admin	$2.800M	$2.400M	$4.700M
YoY Change	-17.65%	-7.69%	11.9%
% of Gross Profit	5.16%	7.55%	11.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$2.000M	$51.64M	$52.13M
YoY Change	-39.39%	-11.45%	-6.53%
Operating Profit	$52.30M	-$19.84M	-$10.33M
YoY Change	276.26%	339.67%	-80.57%
Interest Expense	-$6.400M		$38.43M
YoY Change			5.01%
% of Operating Profit	-12.24%
Other Income/Expense, Net		$5.199M	$3.899M
YoY Change		31.82%	-21.36%
Pretax Income	$45.90M	$24.17M	$31.83M
YoY Change	230.22%	-46.31%	-490.07%
Income Tax	$18.10M	$4.771M	$3.046M
% Of Pretax Income	39.43%	19.74%	9.57%
Net Earnings	$40.84M	$19.40M	$28.78M
YoY Change	31.0%	-45.22%	-646.42%
Net Earnings / Revenue	43.58%	25.59%	34.28%
Basic Earnings Per Share	$0.53	$0.20	$0.39
Diluted Earnings Per Share	$0.50	$0.20	$0.38
COMMON SHARES
Basic Shares Outstanding		66.64M	66.76M
Diluted Shares Outstanding		66.64M	75.23M

Balance Sheet

Concept	2017 Q4	2017 Q3	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$78.00M	$100.0M	$70.00M
YoY Change	129.41%	-28.06%	-27.08%
Cash & Equivalents	$77.65M	$99.52M	$69.89M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$159.0M	$167.0M	$142.0M
YoY Change	34.75%	-25.11%	-21.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$44.00M	$43.00M	$40.00M
YoY Change	51.72%	65.38%	90.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$1.837B	$1.908B
YoY Change		26.69%	61.42%
Other Assets
YoY Change
Total Long-Term Assets	$5.446B	$5.618B	$5.868B
YoY Change	-12.72%	-12.16%	5.06%
TOTAL ASSETS
Total Short-Term Assets	$159.0M	$167.0M	$142.0M
Total Long-Term Assets	$5.446B	$5.618B	$5.868B
Total Assets	$5.605B	$5.785B	$6.010B
YoY Change	-11.84%	-12.6%	4.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$27.00M	$16.00M	$18.00M
YoY Change	68.75%	6.67%	-18.18%
Accrued Expenses	$7.000M	$6.000M	$7.000M
YoY Change	75.0%	200.0%	250.0%
Deferred Revenue
YoY Change
Short-Term Debt	$3.269B	$3.476B	$3.846B
YoY Change	-16.89%	2217.03%	2464.22%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.386B	$3.393B	$3.744B
YoY Change	-14.75%	1124.91%	1762.69%
LONG-TERM LIABILITIES
Long-Term Debt	$599.0M	$689.0M	$774.0M
YoY Change	-33.52%	-24.7%	-6.97%
Other Long-Term Liabilities	$10.00M	$15.00M	$20.00M
YoY Change	-60.0%	-99.63%	-99.39%
Total Long-Term Liabilities	$609.0M	$704.0M	$794.0M
YoY Change	-34.23%	-85.84%	-80.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.386B	$3.393B	$3.744B
Total Long-Term Liabilities	$609.0M	$704.0M	$794.0M
Total Liabilities	$4.060B	$4.174B	$4.555B
YoY Change	-18.9%	-20.7%	3.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$46.67M
YoY Change	74.62%
Common Stock	$1.292B
YoY Change	-6.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.545B	$1.611B	$1.455B
YoY Change
Total Liabilities & Shareholders Equity	$5.605B	$5.785B	$6.010B
YoY Change	-11.84%	-12.6%	4.21%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2017 Q2
OPERATING ACTIVITIES
Net Income	$40.84M	$19.40M	$28.78M
YoY Change	31.0%	-45.22%	-646.42%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$60.00M	-$4.100M	-$108.2M
YoY Change	-135.25%	-99.33%	-22.05%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$266.2M	$286.2M	$87.30M
YoY Change	931.78%	-294.69%	-60.69%
Cash From Investing Activities	$266.2M	$286.2M	$87.30M
YoY Change	931.78%	-294.69%	-60.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-228.0M	-252.6M	-29.20M
YoY Change	-24.1%	-131.43%	-46.52%
NET CHANGE
Cash From Operating Activities	-60.00M	-4.100M	-108.2M
Cash From Investing Activities	266.2M	286.2M	87.30M
Cash From Financing Activities	-228.0M	-252.6M	-29.20M
Net Change In Cash	-21.80M	29.50M	-50.10M
YoY Change	-79.12%	-31.87%	-274.56%
FREE CASH FLOW
Cash From Operating Activities	-$60.00M	-$4.100M	-$108.2M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2015	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	1863000
CY2018Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	60666592
CY2017Q2	dei	Entity Public Float EntityPublicFloat	1195286742
CY2017Q4	us-gaap	Cash Cash	77647000
CY2017Q4	us-gaap	Short Term Investments ShortTermInvestments	18398000
CY2017Q4	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	989461000
CY2017Q4	us-gaap	Mortgages Held For Sale Fair Value Disclosure MortgagesHeldForSaleFairValueDisclosure	1269515000
CY2017Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	1089473000
CY2017Q4	pmt	Excess Spread Investment ExcessSpreadInvestment	236534000
CY2017Q4	us-gaap	Derivative Assets DerivativeAssets	113881000
CY2017Q4	us-gaap	Servicing Asset ServicingAsset	844781000
CY2017Q4	pmt	Servicing Advances ServicingAdvances	77158000
CY2017Q4	pmt	Deposits Securing Credit Risk Transfer Agreements DepositsSecuringCreditRiskTransferAgreements	588867000
CY2017	us-gaap	Operating Expenses OperatingExpenses	193394000
CY2016	us-gaap	Operating Expenses OperatingExpenses	210325000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	124546000
CY2017	us-gaap	Professional Fees ProfessionalFees	6905000
CY2016	us-gaap	Professional Fees ProfessionalFees	6819000
CY2015	us-gaap	Labor And Related Expense LaborAndRelatedExpense	7366000
CY2017Q4	pmt	Servicing Asset Pledged To Creditors ServicingAssetPledgedToCreditors	831892000
CY2017	us-gaap	Gain Loss On Investments GainLossOnInvestments	96384000
CY2016	us-gaap	Gain Loss On Investments GainLossOnInvestments	7175000
CY2015	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	51016000
CY2016	pmt	Loan Originations Fees LoanOriginationsFees	41993000
CY2015	us-gaap	Gain Loss On Investments GainLossOnInvestments	53985000
CY2017	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	74516000
CY2016	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	106442000
CY2016Q4	us-gaap	Pledged Assets Separately Reported Mortgage Related Securities Available For Sale Or Held For Investment PledgedAssetsSeparatelyReportedMortgageRelatedSecuritiesAvailableForSaleOrHeldForInvestment	863802000
CY2016Q4	pmt	Pledged Assets Separately Reported Loans Acquired For Sale Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedLoansAcquiredForSalePledgedAsCollateralAtFairValue	1653748000
CY2016Q4	us-gaap	Pledged Assets Separately Reported Loans Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedLoansPledgedAsCollateralAtFairValue	1712190000
CY2017Q4	pmt	Derivative Assets Pledged To Creditors DerivativeAssetsPledgedToCreditors	26058000
CY2016Q4	pmt	Derivative Assets Pledged To Creditors DerivativeAssetsPledgedToCreditors	9078000
CY2017Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	91459000
CY2017Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	310000000
CY2015	pmt	Loan Originations Fees LoanOriginationsFees	28702000
CY2017	us-gaap	Interest Income Operating InterestIncomeOperating	195176000
CY2016	us-gaap	Interest Income Operating InterestIncomeOperating	222122000
CY2015	us-gaap	Interest Income Operating InterestIncomeOperating	201345000
CY2017	us-gaap	Interest Expense InterestExpense	151371000
CY2016	us-gaap	Interest Expense InterestExpense	149768000
CY2015	us-gaap	Interest Expense InterestExpense	124708000
CY2017	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	43805000
CY2016	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	72354000
CY2015	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	76637000
CY2017	pmt	Net Results Of Real Estate Acquired In Settlement Of Loans NetResultsOfRealEstateAcquiredInSettlementOfLoans	-14955000
CY2016	pmt	Net Results Of Real Estate Acquired In Settlement Of Loans NetResultsOfRealEstateAcquiredInSettlementOfLoans	-19118000
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.16
CY2015	pmt	Net Results Of Real Estate Acquired In Settlement Of Loans NetResultsOfRealEstateAcquiredInSettlementOfLoans	-19177000
CY2017	us-gaap	Other Income OtherIncome	8766000
CY2016	us-gaap	Other Income OtherIncome	8453000
CY2015	us-gaap	Other Income OtherIncome	8283000
CY2017	us-gaap	Revenues Revenues	317940000
CY2016	us-gaap	Revenues Revenues	272088000
CY2015	us-gaap	Revenues Revenues	248765000
CY2017	pmt	Loan Fulfillment Fees Payable To Affiliate LoanFulfillmentFeesPayableToAffiliate	80359000
CY2016	pmt	Loan Fulfillment Fees Payable To Affiliate LoanFulfillmentFeesPayableToAffiliate	86465000
CY2015	pmt	Loan Fulfillment Fees Payable To Affiliate LoanFulfillmentFeesPayableToAffiliate	58607000
CY2017	us-gaap	Loan Portfolio Expense LoanPortfolioExpense	43064000
CY2016	us-gaap	Loan Portfolio Expense LoanPortfolioExpense	50615000
CY2015	us-gaap	Loan Portfolio Expense LoanPortfolioExpense	46423000
CY2017	us-gaap	Management Fee Expense ManagementFeeExpense	22584000
CY2016	us-gaap	Management Fee Expense ManagementFeeExpense	20657000
CY2015	us-gaap	Management Fee Expense ManagementFeeExpense	24194000
CY2017	us-gaap	Loan Processing Fee LoanProcessingFee	7521000
CY2016	us-gaap	Loan Processing Fee LoanProcessingFee	7108000
CY2015	us-gaap	Loan Processing Fee LoanProcessingFee	4686000
CY2015	us-gaap	Professional Fees ProfessionalFees	7306000
CY2017	pmt	Real Estate Held For Investment Expenses RealEstateHeldForInvestmentExpenses	6376000
CY2016	pmt	Real Estate Held For Investment Expenses RealEstateHeldForInvestmentExpenses	3213000
CY2015	pmt	Real Estate Held For Investment Expenses RealEstateHeldForInvestmentExpenses	604000
CY2017	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6322000
CY2016	us-gaap	Labor And Related Expense LaborAndRelatedExpense	7000000
CY2017	pmt	Mortgage Loan Collection And Liquidation Expenses MortgageLoanCollectionAndLiquidationExpenses	6063000
CY2016	pmt	Mortgage Loan Collection And Liquidation Expenses MortgageLoanCollectionAndLiquidationExpenses	13436000
CY2015	pmt	Mortgage Loan Collection And Liquidation Expenses MortgageLoanCollectionAndLiquidationExpenses	10408000
CY2017	us-gaap	Other Expenses OtherExpenses	14200000
CY2016	us-gaap	Other Expenses OtherExpenses	15012000
CY2015	us-gaap	Other Expenses OtherExpenses	15867000
CY2015	us-gaap	Operating Expenses OperatingExpenses	175461000
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	61763000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	73304000
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6797000
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-14047000
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-16796000
CY2017	us-gaap	Net Income Loss NetIncomeLoss	117749000
CY2016	us-gaap	Net Income Loss NetIncomeLoss	75810000
CY2015	us-gaap	Net Income Loss NetIncomeLoss	90100000
CY2017	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	15267000
CY2016	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0
CY2015	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0
CY2017	pmt	Net Income Loss Attributable To Common Stockholders NetIncomeLossAttributableToCommonStockholders	102482000
CY2016	pmt	Net Income Loss Attributable To Common Stockholders NetIncomeLossAttributableToCommonStockholders	75810000
CY2015	pmt	Net Income Loss Attributable To Common Stockholders NetIncomeLossAttributableToCommonStockholders	90100000
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.53
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.09
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.19
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.48
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.08
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66144000
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	68642000
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74446000
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74611000
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77109000
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	83336000
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	1578172000
CY2015	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	6346000
CY2015	us-gaap	Dividends Common Stock DividendsCommonStock	162175000
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8000
CY2015	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	16338000
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	1496113000
CY2016	us-gaap	Dividends Common Stock DividendsCommonStock	128187000
CY2016	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	98370000
CY2017	us-gaap	Dividends Common Stock DividendsCommonStock	123625000
CY2017	us-gaap	Dividends Preferred Stock DividendsPreferredStock	14066000
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	310000000
CY2017	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	91198000
CY2017	pmt	Accrual Of Interest On Excess Servicing Spread Purchased AccrualOfInterestOnExcessServicingSpreadPurchased	16951000
CY2016	pmt	Accrual Of Interest On Excess Servicing Spread Purchased AccrualOfInterestOnExcessServicingSpreadPurchased	22601000
CY2015	pmt	Accrual Of Interest On Excess Servicing Spread Purchased AccrualOfInterestOnExcessServicingSpreadPurchased	25365000
CY2017	pmt	Capitalization Of Interest Advances And Fees On Mortgage Loans At Fair Value CapitalizationOfInterestAdvancesAndFeesOnMortgageLoansAtFairValue	30795000
CY2016	pmt	Capitalization Of Interest Advances And Fees On Mortgage Loans At Fair Value CapitalizationOfInterestAdvancesAndFeesOnMortgageLoansAtFairValue	84820000
CY2015	pmt	Capitalization Of Interest Advances And Fees On Mortgage Loans At Fair Value CapitalizationOfInterestAdvancesAndFeesOnMortgageLoansAtFairValue	57754000
CY2017	us-gaap	Mortgage Servicing Rights Msr Impairment Recovery MortgageServicingRightsMSRImpairmentRecovery	103487000
CY2016	us-gaap	Mortgage Servicing Rights Msr Impairment Recovery MortgageServicingRightsMSRImpairmentRecovery	78628000
CY2015	us-gaap	Mortgage Servicing Rights Msr Impairment Recovery MortgageServicingRightsMSRImpairmentRecovery	53615000
CY2017	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	13769000
CY2016	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	13152000
CY2015	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	11587000
CY2015	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	719000
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	4904000
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	5748000
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	6346000
CY2017	pmt	Payments To Purchase Mortgage Loans Held For Sale Nonaffiliates PaymentsToPurchaseMortgageLoansHeldForSaleNonaffiliates	65830095000
CY2016	pmt	Payments To Purchase Mortgage Loans Held For Sale Nonaffiliates PaymentsToPurchaseMortgageLoansHeldForSaleNonaffiliates	66112316000
CY2015	pmt	Payments To Purchase Mortgage Loans Held For Sale Nonaffiliates PaymentsToPurchaseMortgageLoansHeldForSaleNonaffiliates	46423734000
CY2017	pmt	Payments To Purchase Mortgage Loans Held For Sale Affiliates PaymentsToPurchaseMortgageLoansHeldForSaleAffiliates	904097000
CY2016	pmt	Payments To Purchase Mortgage Loans Held For Sale Affiliates PaymentsToPurchaseMortgageLoansHeldForSaleAffiliates	21541000
CY2015	pmt	Payments To Purchase Mortgage Loans Held For Sale Affiliates PaymentsToPurchaseMortgageLoansHeldForSaleAffiliates	28445000
CY2017	pmt	Proceeds From Repurchase Of Mortgage Loans Subject To Representation And Warranties ProceedsFromRepurchaseOfMortgageLoansSubjectToRepresentationAndWarranties	-11412000
CY2016	pmt	Proceeds From Repurchase Of Mortgage Loans Subject To Representation And Warranties ProceedsFromRepurchaseOfMortgageLoansSubjectToRepresentationAndWarranties	-11380000
CY2017	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	24314165000
CY2015	pmt	Proceeds From Sale Of Mortgage Loans Held For Sale To Affiliates ProceedsFromSaleOfMortgageLoansHeldForSaleToAffiliates	31490920000
CY2016	pmt	Increase Decrease In Servicing Advances IncreaseDecreaseInServicingAdvances	-4672000
CY2015	pmt	Increase Decrease In Servicing Advances IncreaseDecreaseInServicingAdvances	30255000
CY2017	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	-2514000
CY2016	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	-1640000
CY2017	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	9151000
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-863188000
CY2016	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	80223000
CY2015	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-98035000
CY2017	us-gaap	Payments To Acquire Mortgage Servicing Rights Msr PaymentsToAcquireMortgageServicingRightsMSR	79000
CY2016	us-gaap	Payments To Acquire Mortgage Servicing Rights Msr PaymentsToAcquireMortgageServicingRightsMSR	2739000
CY2015	us-gaap	Payments To Acquire Mortgage Servicing Rights Msr PaymentsToAcquireMortgageServicingRightsMSR	2335000
CY2017	pmt	Deposits Of Cash Securing Credit Risk Transfer Agreements DepositsOfCashSecuringCreditRiskTransferAgreements	152641000
CY2016	pmt	Deposits Of Cash Securing Credit Risk Transfer Agreements DepositsOfCashSecuringCreditRiskTransferAgreements	306507000
CY2017	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-8822000
CY2016	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	62028000
CY2015	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	36161000
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-40435000
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	46657000
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7984000
CY2017	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	10656000
CY2016	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	-2549000
CY2017	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	251872000
CY2016	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	765467000
CY2015	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	84828000
CY2017	pmt	Proceeds From Sale And Repayments Of Mortgage Backed Securities Mbs At Fair Value ProceedsFromSaleAndRepaymentsOfMortgageBackedSecuritiesMbsAtFairValue	127591000
CY2016	pmt	Proceeds From Sale And Repayments Of Mortgage Backed Securities Mbs At Fair Value ProceedsFromSaleAndRepaymentsOfMortgageBackedSecuritiesMbsAtFairValue	206508000
CY2015	pmt	Proceeds From Sale And Repayments Of Mortgage Backed Securities Mbs At Fair Value ProceedsFromSaleAndRepaymentsOfMortgageBackedSecuritiesMbsAtFairValue	64459000
CY2017	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	0
CY2016	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	0
CY2015	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	241981000
CY2017	us-gaap	Proceeds From Sale And Collection Of Loans Receivable ProceedsFromSaleAndCollectionOfLoansReceivable	582207000
CY2016	us-gaap	Proceeds From Sale And Collection Of Loans Receivable ProceedsFromSaleAndCollectionOfLoansReceivable	712975000
CY2015	us-gaap	Proceeds From Sale And Collection Of Loans Receivable ProceedsFromSaleAndCollectionOfLoansReceivable	279683000
CY2017	us-gaap	Proceeds From Sale Of Loans Receivable ProceedsFromSaleOfLoansReceivable	0
CY2016	us-gaap	Proceeds From Sale Of Loans Receivable ProceedsFromSaleOfLoansReceivable	891000
CY2015	us-gaap	Proceeds From Sale Of Loans Receivable ProceedsFromSaleOfLoansReceivable	1466000
CY2017	pmt	Payments To Purchase Excess Servicing Spread PaymentsToPurchaseExcessServicingSpread	0
CY2016	pmt	Payments To Purchase Excess Servicing Spread PaymentsToPurchaseExcessServicingSpread	0
CY2015	pmt	Payments To Purchase Excess Servicing Spread PaymentsToPurchaseExcessServicingSpread	271554000
CY2017	pmt	Repayments Of Excess Servicing Spread Investment RepaymentsOfExcessServicingSpreadInvestment	54980000
CY2016	pmt	Repayments Of Excess Servicing Spread Investment RepaymentsOfExcessServicingSpreadInvestment	69992000
CY2015	pmt	Repayments Of Excess Servicing Spread Investment RepaymentsOfExcessServicingSpreadInvestment	78578000
CY2017	pmt	Proceeds From The Sale Of Excess Servicing Spread ProceedsFromTheSaleOfExcessServicingSpread	0
CY2016	pmt	Proceeds From The Sale Of Excess Servicing Spread ProceedsFromTheSaleOfExcessServicingSpread	59045000
CY2015	pmt	Proceeds From The Sale Of Excess Servicing Spread ProceedsFromTheSaleOfExcessServicingSpread	0
CY2015	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	6809000
CY2016	pmt	Proceeds From Sale Of Real Estate Acquired In Settlement Of Loans ProceedsFromSaleOfRealEstateAcquiredInSettlementOfLoans	234684000
CY2015	pmt	Proceeds From Sale Of Real Estate Acquired In Settlement Of Loans ProceedsFromSaleOfRealEstateAcquiredInSettlementOfLoans	240833000
CY2015	us-gaap	Proceeds From Sale Of Mortgage Servicing Rights Msr ProceedsFromSaleOfMortgageServicingRightsMSR	752000
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	10928000
CY2016	pmt	Repayments Of Credit Risk Transfer RepaymentsOfCreditRiskTransfer	0
CY2015	pmt	Repayments Of Credit Risk Transfer RepaymentsOfCreditRiskTransfer	1204187000
CY2017	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	310000000
CY2015	pmt	Deposits Of Cash Securing Credit Risk Transfer Agreements DepositsOfCashSecuringCreditRiskTransferAgreements	147446000
CY2017	pmt	Distributions From Credit Risk Transfer Agreements DistributionsFromCreditRiskTransferAgreements	65564000
CY2016	pmt	Distributions From Credit Risk Transfer Agreements DistributionsFromCreditRiskTransferAgreements	24746000
CY2015	pmt	Distributions From Credit Risk Transfer Agreements DistributionsFromCreditRiskTransferAgreements	1831000
CY2017	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	15163000
CY2016	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-40062000
CY2015	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-8148000
CY2017	us-gaap	Payments To Acquire Federal Home Loan Bank Stock PaymentsToAcquireFederalHomeLoanBankStock	0
CY2016	us-gaap	Payments To Acquire Federal Home Loan Bank Stock PaymentsToAcquireFederalHomeLoanBankStock	225000
CY2015	us-gaap	Payments To Acquire Federal Home Loan Bank Stock PaymentsToAcquireFederalHomeLoanBankStock	7691000
CY2017	us-gaap	Proceeds From Sale Of Federal Home Loan Bank Stock ProceedsFromSaleOfFederalHomeLoanBankStock	0
CY2016	us-gaap	Proceeds From Sale Of Federal Home Loan Bank Stock ProceedsFromSaleOfFederalHomeLoanBankStock	7320000
CY2015	us-gaap	Proceeds From Sale Of Federal Home Loan Bank Stock ProceedsFromSaleOfFederalHomeLoanBankStock	361000
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	681681000
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	193952000
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	11502000
CY2017	pmt	Proceeds From Sale Of Assets Under Agreements To Repurchase ProceedsFromSaleOfAssetsUnderAgreementsToRepurchase	77985354000
CY2016	pmt	Proceeds From Sale Of Assets Under Agreements To Repurchase ProceedsFromSaleOfAssetsUnderAgreementsToRepurchase	70684674000
CY2015	pmt	Proceeds From Sale Of Assets Under Agreements To Repurchase ProceedsFromSaleOfAssetsUnderAgreementsToRepurchase	50133359000
CY2017	pmt	Repayments Of Assets Sold Under Agreements To Repurchase RepaymentsOfAssetsSoldUnderAgreementsToRepurchase	78587535000
CY2016	pmt	Repayments Of Assets Sold Under Agreements To Repurchase RepaymentsOfAssetsSoldUnderAgreementsToRepurchase	70030317000
CY2015	pmt	Repayments Of Assets Sold Under Agreements To Repurchase RepaymentsOfAssetsSoldUnderAgreementsToRepurchase	49733160000
CY2017	pmt	Proceeds From Issuance Of Mortgage Loan Participation Certificates ProceedsFromIssuanceOfMortgageLoanParticipationCertificates	6960713000
CY2016	pmt	Proceeds From Issuance Of Mortgage Loan Participation Certificates ProceedsFromIssuanceOfMortgageLoanParticipationCertificates	6579706000
CY2015	pmt	Proceeds From Issuance Of Mortgage Loan Participation Certificates ProceedsFromIssuanceOfMortgageLoanParticipationCertificates	5009065000
CY2017	pmt	Repayments Of Mortgage Loan Participation Certificates RepaymentsOfMortgageLoanParticipationCertificates	6942079000
CY2016	pmt	Repayments Of Mortgage Loan Participation Certificates RepaymentsOfMortgageLoanParticipationCertificates	6553789000
CY2015	pmt	Repayments Of Mortgage Loan Participation Certificates RepaymentsOfMortgageLoanParticipationCertificates	5029301000
CY2017	us-gaap	Proceeds From Federal Home Loan Bank Advances ProceedsFromFederalHomeLoanBankAdvances	0
CY2016	us-gaap	Proceeds From Federal Home Loan Bank Advances ProceedsFromFederalHomeLoanBankAdvances	28000000
CY2015	us-gaap	Proceeds From Federal Home Loan Bank Advances ProceedsFromFederalHomeLoanBankAdvances	760484000
CY2017	us-gaap	Payments For Federal Home Loan Bank Advances PaymentsForFederalHomeLoanBankAdvances	0
CY2016	us-gaap	Payments For Federal Home Loan Bank Advances PaymentsForFederalHomeLoanBankAdvances	211000000
CY2015	us-gaap	Payments For Federal Home Loan Bank Advances PaymentsForFederalHomeLoanBankAdvances	577484000
CY2017	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	396240000
CY2016	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	129812000
CY2015	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	394242000
CY2017	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	671346000
CY2016	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	90812000
CY2015	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	158343000
CY2017	pmt	Proceeds From Sale Of Asset Backed Secured Financing ProceedsFromSaleOfAssetBackedSecuredFinancing	0
CY2016	pmt	Proceeds From Sale Of Asset Backed Secured Financing ProceedsFromSaleOfAssetBackedSecuredFinancing	182400000
CY2015	pmt	Proceeds From Sale Of Asset Backed Secured Financing ProceedsFromSaleOfAssetBackedSecuredFinancing	110482000
CY2017	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	51687000
CY2016	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	73624000
CY2015	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	24951000
CY2017	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0
CY2016	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0
CY2015	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	168546000
CY2017	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	5872000
CY2016	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0
CY2015	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	18546000
CY2017	pmt	Proceeds From Credit Risk Transfer ProceedsFromCreditRiskTransfer	0
CY2016	pmt	Proceeds From Credit Risk Transfer ProceedsFromCreditRiskTransfer	0
CY2015	pmt	Proceeds From Credit Risk Transfer ProceedsFromCreditRiskTransfer	1204187000
CY2017	pmt	Repayments Of Credit Risk Transfer RepaymentsOfCreditRiskTransfer	0
CY2016	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0
CY2015	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8000
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	91198000
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	98370000
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	16338000
CY2017	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	14066000
CY2016	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0
CY2015	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0
CY2017	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	126135000
CY2016	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	131560000
CY2015	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	173022000
CY2017	pmt	Payment Of Contingent Underwriting Fees PaymentOfContingentUnderwritingFees	61000
CY2016	pmt	Payment Of Contingent Underwriting Fees PaymentOfContingentUnderwritingFees	0
CY2015	pmt	Payment Of Contingent Underwriting Fees PaymentOfContingentUnderwritingFees	705000
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-861635000
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	403959000
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	833408000
CY2017	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	43171000
CY2016	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-23632000
CY2015	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-18278000
CY2015Q4	us-gaap	Cash Cash	58108000
CY2014Q4	us-gaap	Cash Cash	76386000
CY2017	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 33—Recently Issued Accounting Pronouncements</p> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;text-indent:4.54%;">Revenue Recognition</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2014, the FASB issued ASU 2014-09, <font style="font-style:italic;">Revenue from Contracts with Customers (Subtopic 606)</font> (“ASU 2014-09”), which supersedes the guidance in the <font style="font-style:italic;">Revenue Recognition </font>topic of the ASC. ASU 2014-09 clarifies the principles for recognizing revenue in order to improve comparability of revenue recognition practices across entities and industries with certain scope exceptions including financial instruments, leases, and guarantees. ASU 2014-09 provides guidance intended to assist in the identification of contracts with customers and separate performance obligations within those contracts, the determination and allocation of the transaction price to those identified performance obligations and the recognition of revenue when a performance obligation has been satisfied. ASU 2014-09 also requires disclosures regarding the nature, amount, timing, and uncertainty of revenues and cash flows from contracts with customers.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon adoption, ASU 2014-09 provides for transition through either a full retrospective approach requiring the restatement of all presented prior periods or a modified retrospective approach, which allows the new recognition standard to be applied to only those contracts that are not completed at the date of transition. If the modified retrospective approach is adopted, a cumulative-effect adjustment to retained earnings is performed with additional disclosures required including the amount by which each line item is affected by the transition as compared to the guidance in effect before adoption and an explanation of the reasons for significant changes in these amounts.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FASB has issued several amendments to ASU 2014-09, including:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2015, ASU 2015-14, <font style="font-style:italic;">Revenue From Contracts With Customers </font>(“ASU 2015-14”). This update deferred the initial effective date of ASU 2014-09. As a result of the issuance of ASU 2015-14, ASU 2014-09 is effective for annual reporting periods beginning on or after December 15, 2017, and interim periods within those annual periods. Early adoption is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2016, ASU 2016-08, <font style="font-style:italic;">Principal Versus Agent Considerations (Reporting Revenue Gross versus Net)</font>. The amendments to this update are intended to improve the implementation guidance on principal versus agent considerations in ASU 2014-09 by clarifying how an entity should identify the unit of accounting (i.e. the specified good or service) and how an entity should apply the control principle to certain types of arrangements.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2016, ASU 2016-12, <font style="font-style:italic;">Narrow-Scope Improvements and Practical Expedients</font>. The amendments to this update clarify certain core recognition principles and provide practical expedients available at transition. The improvements address collectability, sales tax presentation, noncash consideration, contract modifications and completed contracts at transition.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2016, ASU 2016-20, <font style="font-style:italic;">Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers</font>. The amendments to this update:</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clarify that guarantee fees within the scope of the <font style="font-style:italic;">Guarantees</font> topic of the ASC (other than product or service warranties) are not within the scope of the <font style="font-style:italic;">Revenue from Contracts with Customers</font> topic of the ASC. Entities should see the <font style="font-style:italic;">Derivatives and Hedging</font> topic of the ASC, for guarantees accounted for as derivatives.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clarify the <font style="font-style:italic;">Other Assets and Deferred Costs—Contracts with Customers</font> subtopic of the ASC that when performing impairment testing an entity should (a) consider expected contract renewals and extensions and (b) include both the amount of consideration it already has received but has not recognized as revenue and the amount it expects to receive in the future.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clarify the interaction of impairment testing with guidance in other ASC topics that impairment testing first should be performed on assets not within the scope of the <font style="font-style:italic;">Other Assets and Deferred Costs</font>, <font style="font-style:italic;">Intangibles-Goodwill and Other </font>and the <font style="font-style:italic;">Property, Plant, and Equipment </font>topics (such as assets within the <font style="font-style:italic;">Inventory</font> topic of the ASC), then assets within the scope of the <font style="font-style:italic;">Other Assets and Deferred </font>Costs topic of the ASC, then asset groups and reporting units within the scope of the <font style="font-style:italic;">Other Assets and Deferred Costs</font>, <font style="font-style:italic;">Intangibles-Goodwill and Other</font> and the <font style="font-style:italic;">Property, Plant, and Equipment</font> topics of the ASC.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clarify that all contracts within the scope of the <font style="font-style:italic;">Financial Services – Insurance</font> topic of the ASC are excluded from the scope of the Revenue from Contracts with Customers topic.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provide optional exemptions from the disclosure requirement for remaining performance obligations for specific situations in which an entity need not estimate variable consideration to recognize revenue and expands the information that is required to be disclosed when an entity applies one of the optional exemptions.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clarify that the disclosure of revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods applies to all performance obligations and is not limited to performance obligations with corresponding contract balances.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2017, ASU 2017-05, <font style="font-style:italic;">Other Income—Gains and Losses from the Derecognition of</font> <font style="font-style:italic;">Nonfinancial Assets (Subtopic 610-20)</font> (“ASU 2017-05”). The amendments to this update clarify the scope of the <font style="font-style:italic;">Other Income—Gains and Losses from the Derecognition of Nonfinancial Assets</font> subtopic of the ASC, and to add guidance for partial sales of nonfinancial assets. ASU 2017-05 clarifies that:</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A financial asset is within the scope of the <font style="font-style:italic;">Other Income—Gains and Losses from the Derecognition of Nonfinancial Assets</font> subtopic of the ASC if it meets the definition of an in substance nonfinancial asset and defines the term in substance nonfinancial asset, in part, as a financial asset promised to a counterparty in a contract if substantially all of the fair value of the assets (recognized and unrecognized) that are promised to the counterparty in the contract is concentrated in nonfinancial assets.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">It excludes all businesses and nonprofit activities from the scope of the <font style="font-style:italic;">Other Income – Gains and Losses from the Derecognition of Nonfinancial Assets</font> subtopic of the ASC. Derecognition of all businesses and nonprofit activities should be accounted for in accordance with the <font style="font-style:italic;">Consolidation—Overall</font> subtopic of the ASC.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">An entity should identify each distinct nonfinancial asset or in substance nonfinancial asset promised to a counterparty and derecognize each asset when a counterparty obtains control of it. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">An entity should allocate consideration to each distinct asset by applying the guidance in the <font style="font-style:italic;">Revenue from Contracts with Customers</font> topic of the ASC on allocating the transaction price to performance obligations.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">An entity must derecognize a distinct nonfinancial asset or distinct in substance nonfinancial asset in a partial sale transaction when it (1) does not have (or ceases to have) a controlling financial interest in the legal entity that holds the asset in accordance with the Consolidations topic and (2) transfers control of the asset in accordance with the <font style="font-style:italic;">Revenue from Contracts with Customers </font>topic of the ASC. Once an entity transfers control of a distinct nonfinancial asset or distinct in substance nonfinancial asset, it is required to measure any noncontrolling interest it receives (or retains) at fair value.</p></td></tr></table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Manager has evaluated the effect of adoption of ASU 2014-09 and its amendments and their effect on the Company’s consolidated financial statements, and has concluded that ASU 2014-09 will not have a significant effect on such financial statements.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Fair Value of Financial Instruments</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January 2016, the FASB issued ASU 2016-01, <font style="font-style:italic;">Financial Instruments–Overall: Recognition and Measurement of Financial Assets and Financial Liabilities</font> (“ASU 2016-01”). ASU 2016-01 affects the accounting for equity investments, financial liabilities under the fair value option, the presentation and disclosure requirements for financial instruments, and the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ASU 2016-01 requires that:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All equity investments in unconsolidated entities (other than those accounted for using the equity method of accounting) with readily determinable fair values will generally be measured at fair value through earnings.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When the fair value option has been elected for financial liabilities, changes in fair value due to instrument-specific credit risk will be recognized separately in other comprehensive income. The accumulated gains and losses due to these changes will be reclassified from accumulated other comprehensive income to earnings if the financial liability is settled before maturity.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For financial instruments measured at amortized cost, public business entities will be required to use the exit price when measuring the fair value of financial instruments for disclosure purposes.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial assets and financial liabilities shall be presented separately in the notes to the financial statements, grouped by measurement category (e.g., fair value, amortized cost, lower of cost or fair value) and form of financial asset (e.g., loans, securities).</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Public business entities will no longer be required to disclose the methods and significant assumptions used to estimate the fair value of financial instruments carried at amortized cost.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Entities will have to assess the realizability of a deferred tax asset related to a debt security classified as available for sale in combination with the entity’s other deferred tax assets.</p></td></tr></table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The classification and measurement guidance will be effective for public business entities in fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption of the provision to record fair value changes for financial liabilities under the fair value option resulting from instrument-specific credit risk in other comprehensive income is permitted and can be elected for all financial statements of fiscal years and interim periods that have not yet been issued or that have not yet been made available for issuance. The Manager does not believe that the adoption of ASU 2016-01 will have a significant effect on its consolidated financial statements.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Statement of Cash Flows</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November of 2016, the FASB issued ASU 2016-18, <font style="font-style:italic;">Statement of Cash Flows (Topic 230)</font> (“ASU 2016-18”). ASU 2016-18 requires that a statement of cash flows explain the change during the reporting period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The amendments in ASU 2016-18 do not provide a definition of restricted cash or restricted cash equivalents. The amendments in ASU 2016-18 are effective for the Company’s fiscal year, including interim periods within the fiscal year ending December 31, 2018. The Manager does not believe the adoption of ASU 2016-18 will have a significant effect on the Company’s consolidated statement of cash flows</p></div>
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;text-indent:4.54%;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Preparation of financial statements in compliance with GAAP requires the Manager to make estimates and judgments that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, and revenues and expenses during the reporting period. Actual results will likely differ from those estimates. </p></div>
CY2017	us-gaap	Schedule Of Repurchase Agreements ScheduleOfRepurchaseAgreements	<div> <p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Following is a summary of maturities of outstanding assets sold under agreements to repurchase by facility maturity date:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:60%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:73.68%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Remaining maturity at December 31, 2017</font></p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.2%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual balance</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.84%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:73.68%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.2%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.84%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:73.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Within 30 days</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.42%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,276,308</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.84%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:73.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over 30 to 90 days</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.42%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">407,902</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.84%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:73.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over 90 days to 180 days</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.42%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">743,971</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.84%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:73.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over 180 days to 1 year</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.42%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">654,283</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.84%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:73.68%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over one year to two years</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,040</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.84%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:73.68%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.26%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,182,504</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.84%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:73.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average maturity (in months)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.42%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.0</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.84%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p></div>
CY2017Q4	pmt	Fair Value Of Distressed Mortgage Loans Purchased And Reo Held FairValueOfDistressedMortgageLoansPurchasedAndReoHeld	931298000
CY2016Q4	pmt	Fair Value Of Distressed Mortgage Loans Purchased And Reo Held FairValueOfDistressedMortgageLoansPurchasedAndReoHeld	1628641000
CY2017	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4
CY2017	pmt	Reit Qualification Threshold Percentage Of Taxable Income For Distribution ReitQualificationThresholdPercentageOfTaxableIncomeForDistribution	0.90
CY2017	pmt	Fair Value Purchased Of Mortgage Loans Investment Portfolio Purchases From Or Through One Or More Subsidiaries FairValuePurchasedOfMortgageLoansInvestmentPortfolioPurchasesFromOrThroughOneOrMoreSubsidiaries	860860000
CY2016	pmt	Fair Value Purchased Of Mortgage Loans Investment Portfolio Purchases From Or Through One Or More Subsidiaries FairValuePurchasedOfMortgageLoansInvestmentPortfolioPurchasesFromOrThroughOneOrMoreSubsidiaries	1487150000
CY2017Q4	us-gaap	Cost Method Investments CostMethodInvestments	0
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	0
CY2017	pmt	Loans Delinquent Period LoansDelinquentPeriod	90 or more days
CY2017	pmt	Servicing Fee Percentage ServicingFeePercentage	0.0025
CY2017	pmt	Mortgage Servicing Rights Fair Value Option Threshold Loan Interest Rate MortgageServicingRightsFairValueOptionThresholdLoanInterestRate	0.045
CY2017	pmt	Initial Interest Rates InitialInterestRates	More than 4.5%.
CY2017	pmt	Mortgage Loans Description Of Variable Rate Basis MortgageLoansDescriptionOfVariableRateBasis	Note interest rate pools of 50 basis points for note interest rates between 3.0% and 4.5% and a single pool for note interest rates below 3%. Adjustable rate mortgage loans with initial interest rates of 4.5% or less are evaluated in a single pool.
CY2017	pmt	Mortgage Loans Description MortgageLoansDescription	Note interest rate pools of 50 basis points
CY2017	pmt	Basis Point For Mortgage Loan BasisPointForMortgageLoan	0.0050
CY2017	pmt	Percentage Of Income Tax Positions Likely To Be Realized PercentageOfIncomeTaxPositionsLikelyToBeRealized	0.50
CY2016Q1	pmt	Proceeds From The Sale Of Excess Servicing Spread ProceedsFromTheSaleOfExcessServicingSpread	59000000
CY2016Q4	pmt	Excess Service Spread Recapture Of Minimum Percentage Loan Fee Rate And Unpaid Principal Balance Refinance Mortgage Loans ExcessServiceSpreadRecaptureOfMinimumPercentageLoanFeeRateAndUnpaidPrincipalBalanceRefinanceMortgageLoans	0.90
CY2016Q4	pmt	Excess Service Spread Recapture Of Minimum Percentage Loan Fee Rate And Unpaid Principal Balance Modified Mortgage Loans ExcessServiceSpreadRecaptureOfMinimumPercentageLoanFeeRateAndUnpaidPrincipalBalanceModifiedMortgageLoans	0.90
CY2017Q4	pmt	Fair Value Option Loans Held As Assets Aggregate Fair Value FairValueOptionLoansHeldAsAssetsAggregateFairValue	1089473000
CY2016Q4	pmt	Fair Value Option Loans Held As Assets Aggregate Fair Value FairValueOptionLoansHeldAsAssetsAggregateFairValue	1721741000
CY2017Q4	us-gaap	Mortgage Loans On Real Estate Principal Amount Of Delinquent Loans MortgageLoansOnRealEstatePrincipalAmountOfDelinquentLoans	1360642000
CY2016Q4	us-gaap	Mortgage Loans On Real Estate Principal Amount Of Delinquent Loans MortgageLoansOnRealEstatePrincipalAmountOfDelinquentLoans	2208183000
CY2017Q4	us-gaap	Fair Value Option Loans Held As Assets Aggregate Difference FairValueOptionLoansHeldAsAssetsAggregateDifference	-271169000
CY2016Q4	us-gaap	Fair Value Option Loans Held As Assets Aggregate Difference FairValueOptionLoansHeldAsAssetsAggregateDifference	-486442000
CY2017Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	244900000
CY2016Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	240700000
CY2017	pmt	Servicing Asset At Fair Value Additions From Loan Sales ServicingAssetAtFairValueAdditionsFromLoanSales	41379000
CY2016	pmt	Servicing Asset At Fair Value Additions From Loan Sales ServicingAssetAtFairValueAdditionsFromLoanSales	7337000
CY2015	pmt	Servicing Asset At Fair Value Additions From Loan Sales ServicingAssetAtFairValueAdditionsFromLoanSales	13963000
CY2017	pmt	Fair Value Unpaid Principal Balance Of Underlying Loans FairValueUnpaidPrincipalBalanceOfUnderlyingLoans	3724642000
CY2016	pmt	Fair Value Unpaid Principal Balance Of Underlying Loans FairValueUnpaidPrincipalBalanceOfUnderlyingLoans	752850000
CY2015	pmt	Fair Value Unpaid Principal Balance Of Underlying Loans FairValueUnpaidPrincipalBalanceOfUnderlyingLoans	1430795000
CY2017	pmt	Services Fee Annual Rate ServicesFeeAnnualRate	0.0025
CY2016	pmt	Services Fee Annual Rate ServicesFeeAnnualRate	0.0026
CY2015	pmt	Services Fee Annual Rate ServicesFeeAnnualRate	0.0025
CY2017	us-gaap	Servicing Asset At Amortized Value Additions ServicingAssetAtAmortizedValueAdditions	248930000
CY2016	us-gaap	Servicing Asset At Amortized Value Additions ServicingAssetAtAmortizedValueAdditions	267755000
CY2015	us-gaap	Servicing Asset At Amortized Value Additions ServicingAssetAtAmortizedValueAdditions	140511000
CY2017	pmt	Amortized Cost Unpaid Principal Balance Of Underlying Loans AmortizedCostUnpaidPrincipalBalanceOfUnderlyingLoans	19982686000
CY2016	pmt	Amortized Cost Unpaid Principal Balance Of Underlying Loans AmortizedCostUnpaidPrincipalBalanceOfUnderlyingLoans	22068577000
CY2015	pmt	Amortized Cost Unpaid Principal Balance Of Underlying Loans AmortizedCostUnpaidPrincipalBalanceOfUnderlyingLoans	12195574000
CY2017	pmt	Percentage Of Amortized Cost PercentageOfAmortizedCost	0.0025
CY2016	pmt	Percentage Of Amortized Cost PercentageOfAmortizedCost	0.0025
CY2015	pmt	Percentage Of Amortized Cost PercentageOfAmortizedCost	0.0025
CY2017Q4	pmt	Fair Value Unpaid Principal Of Underlying Loans Balance FairValueUnpaidPrincipalOfUnderlyingLoansBalance	8273696000
CY2016Q4	pmt	Fair Value Unpaid Principal Of Underlying Loans Balance FairValueUnpaidPrincipalOfUnderlyingLoansBalance	5763957000
CY2017Q4	pmt	Annual Service Fee Rate AnnualServiceFeeRate	0.0025
CY2016Q4	pmt	Annual Service Fee Rate AnnualServiceFeeRate	0.0025
CY2017	pmt	Fair Value Weighted Average Coupon Interest Rate FairValueWeightedAverageCouponInterestRate	0.047
CY2016	pmt	Fair Value Weighted Average Coupon Interest Rate FairValueWeightedAverageCouponInterestRate	0.047
CY2017Q4	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	753322000
CY2016Q4	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	592431000
CY2017	pmt	Amortized Cost Unpaid Principal Balance Of Underlying Loans Period End AmortizedCostUnpaidPrincipalBalanceOfUnderlyingLoansPeriodEnd	63853606000
CY2016	pmt	Amortized Cost Unpaid Principal Balance Of Underlying Loans Period End AmortizedCostUnpaidPrincipalBalanceOfUnderlyingLoansPeriodEnd	50539707000
CY2017	pmt	Weighted Average Servicing Fee Rate Amortized Cost WeightedAverageServicingFeeRateAmortizedCost	0.0025
CY2016	pmt	Weighted Average Servicing Fee Rate Amortized Cost WeightedAverageServicingFeeRateAmortizedCost	0.0025
CY2017	pmt	Amortized Cost Weighted Average Coupon Interest Rate AmortizedCostWeightedAverageCouponInterestRate	0.039
CY2016	pmt	Amortized Cost Weighted Average Coupon Interest Rate AmortizedCostWeightedAverageCouponInterestRate	0.038
CY2017Q4	pmt	Pledged Financial Instruments Not Separately Reported And Assets Separately Reported On Statement At Fair Value PledgedFinancialInstrumentsNotSeparatelyReportedAndAssetsSeparatelyReportedOnStatementAtFairValue	1249277000
CY2016Q4	pmt	Pledged Financial Instruments Not Separately Reported And Assets Separately Reported On Statement At Fair Value PledgedFinancialInstrumentsNotSeparatelyReportedAndAssetsSeparatelyReportedOnStatementAtFairValue	1653748000
CY2017Q4	pmt	Mortgage Loans On Real Estate Unpaid Balance MortgageLoansOnRealEstateUnpaidBalance	1360642000
CY2016Q4	pmt	Mortgage Loans On Real Estate Unpaid Balance MortgageLoansOnRealEstateUnpaidBalance	2208183000
CY2017Q4	pmt	Mortgage Loans At Fair Value Held By Variable Interest Entity MortgageLoansAtFairValueHeldByVariableInterestEntity	321040000
CY2016Q4	pmt	Mortgage Loans At Fair Value Held By Variable Interest Entity MortgageLoansAtFairValueHeldByVariableInterestEntity	367169000
CY2017Q4	pmt	Percentage Of Mortgage Loan Portfolio PercentageOfMortgageLoanPortfolio	0.73
CY2016Q4	pmt	Percentage Of Mortgage Loan Portfolio PercentageOfMortgageLoanPortfolio	0.72
CY2017Q4	pmt	Percentage Of Fair Value Mortgage Loan Portfolio PercentageOfFairValueMortgageLoanPortfolio	0.38
CY2016Q4	pmt	Percentage Of Fair Value Mortgage Loan Portfolio PercentageOfFairValueMortgageLoanPortfolio	0.41
CY2017Q4	pmt	Ratio Of Loans With Unpaid Principal Balance To Current Property Value RatioOfLoansWithUnpaidPrincipalBalanceToCurrentPropertyValue	1.00
CY2016	pmt	Gains Losses Real Estate Owned Net GainsLossesRealEstateOwnedNet	-19118000
CY2015	pmt	Gains Losses Real Estate Owned Net GainsLossesRealEstateOwnedNet	-19177000
CY2017	us-gaap	Sales Of Real Estate SalesOfRealEstate	166921000
CY2016	us-gaap	Sales Of Real Estate SalesOfRealEstate	234684000
CY2016Q4	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Liability DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedLiability	0
CY2016Q4	us-gaap	Cash Collateral For Borrowed Securities CashCollateralForBorrowedSecurities	0
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	33709000
CY2017Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross	3184191000
CY2015	us-gaap	Sales Of Real Estate SalesOfRealEstate	240833000
CY2017Q4	pmt	Real Estate Acquired Through Foreclosure Pledged To Secure Borrowings RealEstateAcquiredThroughForeclosurePledgedToSecureBorrowings	76037000
CY2016Q4	pmt	Ratio Of Loans With Unpaid Principal Balance To Current Property Value RatioOfLoansWithUnpaidPrincipalBalanceToCurrentPropertyValue	1.00
CY2017Q4	pmt	Percentage Of Estimated Fair Value Of Mortgage Loans Originated PercentageOfEstimatedFairValueOfMortgageLoansOriginated	0.05
CY2016Q4	pmt	Percentage Of Estimated Fair Value Of Mortgage Loans Originated PercentageOfEstimatedFairValueOfMortgageLoansOriginated	0.05
CY2017Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	115803000
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	71093000
CY2017Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	1922000
CY2016Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	37384000
CY2017Q4	pmt	Margin Deposit Assets Liabilities MarginDepositAssetsLiabilities	76000
CY2016Q4	pmt	Margin Deposit Assets Liabilities MarginDepositAssetsLiabilities	-18071000
CY2017Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	3305000
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	28885000
CY2017Q4	us-gaap	Derivative Liability Collateral Right To Reclaim Cash Offset DerivativeLiabilityCollateralRightToReclaimCashOffset	1999000
CY2016Q4	us-gaap	Derivative Liability Collateral Right To Reclaim Cash Offset DerivativeLiabilityCollateralRightToReclaimCashOffset	19312000
CY2017Q4	pmt	Derivative Asset Netting DerivativeAssetNetting	1922000
CY2016Q4	pmt	Derivative Asset Netting DerivativeAssetNetting	37384000
CY2017Q4	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Liability DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedLiability	0
CY2017Q4	us-gaap	Cash Collateral For Borrowed Securities CashCollateralForBorrowedSecurities	0
CY2017Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	113881000
CY2017Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset	1999000
CY2017Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned	3182192000
CY2016Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross	3812886000
CY2016Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset	19312000
CY2016Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned	3793574000
CY2017Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities	3180886000
CY2017Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash	0
CY2017Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral	1306000
CY2016Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities	3784001000
CY2016Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash	0
CY2016Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral	9573000
CY2015Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	341846000
CY2014Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	303228000
CY2017	pmt	Real Estate Acquired In Satisfaction Of Debt RealEstateAcquiredInSatisfactionOfDebt	87202000
CY2016	pmt	Real Estate Acquired In Satisfaction Of Debt RealEstateAcquiredInSatisfactionOfDebt	207431000
CY2015	pmt	Real Estate Acquired In Satisfaction Of Debt RealEstateAcquiredInSatisfactionOfDebt	307455000
CY2017	us-gaap	Transfer Of Other Real Estate TransferOfOtherRealEstate	16530000
CY2016	us-gaap	Transfer Of Other Real Estate TransferOfOtherRealEstate	21406000
CY2015	us-gaap	Transfer Of Other Real Estate TransferOfOtherRealEstate	8827000
CY2017	us-gaap	Other Real Estate Valuation Adjustments OtherRealEstateValuationAdjustments	-27505000
CY2016	us-gaap	Other Real Estate Valuation Adjustments OtherRealEstateValuationAdjustments	-36193000
CY2015	us-gaap	Other Real Estate Valuation Adjustments OtherRealEstateValuationAdjustments	-40432000
CY2017	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	12550000
CY2016	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	17075000
CY2015	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	21255000
CY2017	pmt	Gains Losses Real Estate Owned Net GainsLossesRealEstateOwnedNet	-14955000
CY2016Q4	pmt	Real Estate Acquired Through Foreclosure Pledged To Secure Borrowings RealEstateAcquiredThroughForeclosurePledgedToSecureBorrowings	167430000
CY2015Q4	pmt	Real Estate Acquired Through Foreclosure Pledged To Secure Borrowings RealEstateAcquiredThroughForeclosurePledgedToSecureBorrowings	0
CY2017Q4	pmt	Real Estate Owned Held In Subsidiary For Financing Purposes RealEstateOwnedHeldInSubsidiaryForFinancingPurposes	48495000
CY2016Q4	pmt	Real Estate Owned Held In Subsidiary For Financing Purposes RealEstateOwnedHeldInSubsidiaryForFinancingPurposes	48283000
CY2015Q4	pmt	Real Estate Owned Held In Subsidiary For Financing Purposes RealEstateOwnedHeldInSubsidiaryForFinancingPurposes	0
CY2017Q4	us-gaap	Pledged Assets Separately Reported Real Estate Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedRealEstatePledgedAsCollateralAtFairValue	124532000
CY2016Q4	us-gaap	Pledged Assets Separately Reported Real Estate Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedRealEstatePledgedAsCollateralAtFairValue	215713000
CY2015Q4	us-gaap	Pledged Assets Separately Reported Real Estate Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedRealEstatePledgedAsCollateralAtFairValue	0
CY2016Q4	pmt	Servicing Asset At Amortized Cost Before Valuation Allowance ServicingAssetAtAmortizedCostBeforeValuationAllowance	606103000
CY2015Q4	pmt	Servicing Asset At Amortized Cost Before Valuation Allowance ServicingAssetAtAmortizedCostBeforeValuationAllowance	404101000
CY2014Q4	pmt	Servicing Asset At Amortized Cost Before Valuation Allowance ServicingAssetAtAmortizedCostBeforeValuationAllowance	308137000
CY2017	us-gaap	Amortization Of Mortgage Servicing Rights Ms Rs AmortizationOfMortgageServicingRightsMSRs	81624000
CY2016	us-gaap	Amortization Of Mortgage Servicing Rights Ms Rs AmortizationOfMortgageServicingRightsMSRs	65647000
CY2015	us-gaap	Amortization Of Mortgage Servicing Rights Ms Rs AmortizationOfMortgageServicingRightsMSRs	43982000
CY2017	us-gaap	Servicing Asset At Amortized Value Disposals ServicingAssetAtAmortizedValueDisposals	539000
CY2016	us-gaap	Servicing Asset At Amortized Value Disposals ServicingAssetAtAmortizedValueDisposals	106000
CY2015	us-gaap	Servicing Asset At Amortized Value Disposals ServicingAssetAtAmortizedValueDisposals	565000
CY2016Q4	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Balance ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance	13672000
CY2015Q4	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Balance ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance	10944000
CY2014Q4	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Balance ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance	7715000
CY2017	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Provisions Recoveries ValuationAllowanceForImpairmentOfRecognizedServicingAssetsProvisionsRecoveries	5876000
CY2016	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Provisions Recoveries ValuationAllowanceForImpairmentOfRecognizedServicingAssetsProvisionsRecoveries	2728000
CY2015	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Provisions Recoveries ValuationAllowanceForImpairmentOfRecognizedServicingAssetsProvisionsRecoveries	3229000
CY2017Q4	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Balance ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance	19548000
CY2015Q4	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	393157000
CY2016Q4	us-gaap	Servicing Asset At Amortized Value Fair Value ServicingAssetAtAmortizedValueFairValue	626334000
CY2015Q4	us-gaap	Servicing Asset At Amortized Value Fair Value ServicingAssetAtAmortizedValueFairValue	424154000
CY2014Q4	us-gaap	Servicing Asset At Amortized Value Fair Value ServicingAssetAtAmortizedValueFairValue	322230000
CY2017Q4	us-gaap	Servicing Asset At Amortized Value Fair Value ServicingAssetAtAmortizedValueFairValue	772940000
CY2017Q4	pmt	Ms Rs Carried At Lower Of Cost Or Fair Value Pledged To Secure Assets Sold Under Agreements To Repurchase MSRsCarriedAtLowerOfCostOrFairValuePledgedToSecureAssetsSoldUnderAgreementsToRepurchase	584762000
CY2016Q4	pmt	Ms Rs Carried At Lower Of Cost Or Fair Value Pledged To Secure Assets Sold Under Agreements To Repurchase MSRsCarriedAtLowerOfCostOrFairValuePledgedToSecureAssetsSoldUnderAgreementsToRepurchase	0
CY2017Q4	pmt	Ms Rs Carried At Lower Of Cost Or Fair Value Pledged To Secure Notes Payable MSRsCarriedAtLowerOfCostOrFairValuePledgedToSecureNotesPayable	156846000
CY2016Q4	pmt	Ms Rs Carried At Lower Of Cost Or Fair Value Pledged To Secure Notes Payable MSRsCarriedAtLowerOfCostOrFairValuePledgedToSecureNotesPayable	592431000
CY2017Q4	pmt	Ms Rs Carried At Lower Of Cost Or Fair Value Pledged To Secure MSRsCarriedAtLowerOfCostOrFairValuePledgedToSecure	741608000
CY2016Q4	pmt	Ms Rs Carried At Lower Of Cost Or Fair Value Pledged To Secure MSRsCarriedAtLowerOfCostOrFairValuePledgedToSecure	592431000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	93420000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	85561000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	77320000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	69239000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	61758000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	385572000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	772870000
CY2015Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	66584000
CY2017	pmt	Mortgage Servicing Rights Fair Value Purchases MortgageServicingRightsFairValuePurchases	79000
CY2016	pmt	Mortgage Servicing Rights Fair Value Purchases MortgageServicingRightsFairValuePurchases	2739000
CY2015	pmt	Mortgage Servicing Rights Fair Value Purchases MortgageServicingRightsFairValuePurchases	2335000
CY2017	us-gaap	Servicing Asset At Fair Value Changes In Fair Value Resulting From Changes In Valuation Inputs Or Changes In Assumptions ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputsOrChangesInAssumptions	-9762000
CY2016	us-gaap	Servicing Asset At Fair Value Changes In Fair Value Resulting From Changes In Valuation Inputs Or Changes In Assumptions ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputsOrChangesInAssumptions	-3210000
CY2015	us-gaap	Servicing Asset At Fair Value Changes In Fair Value Resulting From Changes In Valuation Inputs Or Changes In Assumptions ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputsOrChangesInAssumptions	312000
CY2017	us-gaap	Servicing Asset At Fair Value Other Changes In Fair Value ServicingAssetAtFairValueOtherChangesInFairValue	-4373000
CY2016	us-gaap	Servicing Asset At Fair Value Other Changes In Fair Value ServicingAssetAtFairValueOtherChangesInFairValue	-9314000
CY2015	us-gaap	Servicing Asset At Fair Value Other Changes In Fair Value ServicingAssetAtFairValueOtherChangesInFairValue	-7384000
CY2016	us-gaap	Servicing Asset At Fair Value Period Increase Decrease ServicingAssetAtFairValuePeriodIncreaseDecrease	-12524000
CY2015	us-gaap	Late Fee Income Generated By Servicing Financial Assets Amount LateFeeIncomeGeneratedByServicingFinancialAssetsAmount	328000
CY2015	us-gaap	Servicing Asset At Fair Value Period Increase Decrease ServicingAssetAtFairValuePeriodIncreaseDecrease	-7072000
CY2017Q4	pmt	Mortgage Servicing Rights At Fair Value Pledged To Secure Assets Sold Under Agreements To Repurchase MortgageServicingRightsAtFairValuePledgedToSecureAssetsSoldUnderAgreementsToRepurchase	66813000
CY2016Q4	pmt	Mortgage Servicing Rights At Fair Value Pledged To Secure Assets Sold Under Agreements To Repurchase MortgageServicingRightsAtFairValuePledgedToSecureAssetsSoldUnderAgreementsToRepurchase	0
CY2017Q4	pmt	Mortgage Servicing Rights At Fair Value Pledged To Secure Notes Payable MortgageServicingRightsAtFairValuePledgedToSecureNotesPayable	23471000
CY2016Q4	pmt	Mortgage Servicing Rights At Fair Value Pledged To Secure Notes Payable MortgageServicingRightsAtFairValuePledgedToSecureNotesPayable	64136000
CY2017Q4	pmt	Mortgage Servicing Rights At Fair Value Pledged To Secure MortgageServicingRightsAtFairValuePledgedToSecure	90284000
CY2016Q4	pmt	Mortgage Servicing Rights At Fair Value Pledged To Secure MortgageServicingRightsAtFairValuePledgedToSecure	64136000
CY2017	us-gaap	Contractually Specified Servicing Fees Amount ContractuallySpecifiedServicingFeesAmount	164776000
CY2016	us-gaap	Contractually Specified Servicing Fees Amount ContractuallySpecifiedServicingFeesAmount	125961000
CY2017	us-gaap	Late Fee Income Generated By Servicing Financial Assets Amount LateFeeIncomeGeneratedByServicingFinancialAssetsAmount	718000
CY2016	us-gaap	Late Fee Income Generated By Servicing Financial Assets Amount LateFeeIncomeGeneratedByServicingFinancialAssetsAmount	570000
CY2017	us-gaap	Ancillary Fee Income Generated By Servicing Financial Assets Amount AncillaryFeeIncomeGeneratedByServicingFinancialAssetsAmount	5805000
CY2016	us-gaap	Ancillary Fee Income Generated By Servicing Financial Assets Amount AncillaryFeeIncomeGeneratedByServicingFinancialAssetsAmount	5302000
CY2015	us-gaap	Ancillary Fee Income Generated By Servicing Financial Assets Amount AncillaryFeeIncomeGeneratedByServicingFinancialAssetsAmount	4186000
CY2017	us-gaap	Contractually Specified Servicing Fees Late Fees And Ancillary Fees Earned In Exchange For Servicing Financial Assets ContractuallySpecifiedServicingFeesLateFeesAndAncillaryFeesEarnedInExchangeForServicingFinancialAssets	171299000
CY2016	us-gaap	Contractually Specified Servicing Fees Late Fees And Ancillary Fees Earned In Exchange For Servicing Financial Assets ContractuallySpecifiedServicingFeesLateFeesAndAncillaryFeesEarnedInExchangeForServicingFinancialAssets	131833000
CY2015	us-gaap	Contractually Specified Servicing Fees Late Fees And Ancillary Fees Earned In Exchange For Servicing Financial Assets ContractuallySpecifiedServicingFeesLateFeesAndAncillaryFeesEarnedInExchangeForServicingFinancialAssets	102147000
CY2017	pmt	Securities Sold Under Agreements To Repurchase Weighted Average Interest Rate During Period SecuritiesSoldUnderAgreementsToRepurchaseWeightedAverageInterestRateDuringPeriod	0.0249
CY2016	pmt	Securities Sold Under Agreements To Repurchase Weighted Average Interest Rate During Period SecuritiesSoldUnderAgreementsToRepurchaseWeightedAverageInterestRateDuringPeriod	0.0244
CY2015	pmt	Securities Sold Under Agreements To Repurchase Weighted Average Interest Rate During Period SecuritiesSoldUnderAgreementsToRepurchaseWeightedAverageInterestRateDuringPeriod	0.0233
CY2017	pmt	Assets Sold Under Agreements To Repurchase Average Balance AssetsSoldUnderAgreementsToRepurchaseAverageBalance	3332084000
CY2016	pmt	Assets Sold Under Agreements To Repurchase Average Balance AssetsSoldUnderAgreementsToRepurchaseAverageBalance	3382528000
CY2015	pmt	Assets Sold Under Agreements To Repurchase Average Balance AssetsSoldUnderAgreementsToRepurchaseAverageBalance	3046963000
CY2017	us-gaap	Interest Expense Securities Sold Under Agreements To Repurchase InterestExpenseSecuritiesSoldUnderAgreementsToRepurchase	93580000
CY2016	us-gaap	Interest Expense Securities Sold Under Agreements To Repurchase InterestExpenseSecuritiesSoldUnderAgreementsToRepurchase	92838000
CY2015	us-gaap	Interest Expense Securities Sold Under Agreements To Repurchase InterestExpenseSecuritiesSoldUnderAgreementsToRepurchase	79869000
CY2017	pmt	Asset Sold Under Agreements To Repurchase Maximum Daily Amount Outstanding AssetSoldUnderAgreementsToRepurchaseMaximumDailyAmountOutstanding	4242600000
CY2016	pmt	Asset Sold Under Agreements To Repurchase Maximum Daily Amount Outstanding AssetSoldUnderAgreementsToRepurchaseMaximumDailyAmountOutstanding	5573021000
CY2015	pmt	Asset Sold Under Agreements To Repurchase Maximum Daily Amount Outstanding AssetSoldUnderAgreementsToRepurchaseMaximumDailyAmountOutstanding	4710412000
CY2017Q4	pmt	Assets Sold Under Agreements To Repurchase AssetsSoldUnderAgreementsToRepurchase	3182504000
CY2016Q4	pmt	Assets Sold Under Agreements To Repurchase AssetsSoldUnderAgreementsToRepurchase	3784685000
CY2017	pmt	Securities Sold Under Agreements To Repurchase Weighted Average Interest Rate At Period End SecuritiesSoldUnderAgreementsToRepurchaseWeightedAverageInterestRateAtPeriodEnd	0.0277
CY2016	pmt	Securities Sold Under Agreements To Repurchase Weighted Average Interest Rate At Period End SecuritiesSoldUnderAgreementsToRepurchaseWeightedAverageInterestRateAtPeriodEnd	0.0270
CY2017	pmt	Assets Sold Under Agreements Available Borrowing Capacity Committed AssetsSoldUnderAgreementsAvailableBorrowingCapacityCommitted	749650000
CY2016	pmt	Assets Sold Under Agreements Available Borrowing Capacity Committed AssetsSoldUnderAgreementsAvailableBorrowingCapacityCommitted	518932000
CY2017	pmt	Securities Sold Under Agreements Available Borrowing Capacity Uncommitted SecuritiesSoldUnderAgreementsAvailableBorrowingCapacityUncommitted	2030607000
CY2016	pmt	Securities Sold Under Agreements Available Borrowing Capacity Uncommitted SecuritiesSoldUnderAgreementsAvailableBorrowingCapacityUncommitted	1092253000
CY2017	pmt	Securities Sold Under Agreements Available Borrowing Capacity SecuritiesSoldUnderAgreementsAvailableBorrowingCapacity	2780257000
CY2016	pmt	Securities Sold Under Agreements Available Borrowing Capacity SecuritiesSoldUnderAgreementsAvailableBorrowingCapacity	1611185000
CY2017Q4	us-gaap	Good Faith And Margin Deposits With Broker Dealers GoodFaithAndMarginDepositsWithBrokerDealers	28154000
CY2016Q4	us-gaap	Good Faith And Margin Deposits With Broker Dealers GoodFaithAndMarginDepositsWithBrokerDealers	29634000
CY2017Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	3182504000
CY2017	pmt	Repurchase Agreements Weighted Average Maturity Period RepurchaseAgreementsWeightedAverageMaturityPeriod	P4M
CY2016	pmt	Federal Home Loan Bank Advances Weighted Average Interest Rate During Period FederalHomeLoanBankAdvancesWeightedAverageInterestRateDuringPeriod	0.0049
CY2015	pmt	Federal Home Loan Bank Advances Weighted Average Interest Rate During Period FederalHomeLoanBankAdvancesWeightedAverageInterestRateDuringPeriod	0.0030
CY2016	us-gaap	Federal Home Loan Bank Advances Activity For Year Average Balance Of Agreements Outstanding FederalHomeLoanBankAdvancesActivityForYearAverageBalanceOfAgreementsOutstanding	24375000
CY2015	us-gaap	Federal Home Loan Bank Advances Activity For Year Average Balance Of Agreements Outstanding FederalHomeLoanBankAdvancesActivityForYearAverageBalanceOfAgreementsOutstanding	89512000
CY2016	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm	122000
CY2015	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm	275000
CY2016Q4	pmt	Federal Home Loan Bank Advances Activity For Year Maximum Daily Amount Outstanding FederalHomeLoanBankAdvancesActivityForYearMaximumDailyAmountOutstanding	201130000
CY2015Q4	pmt	Federal Home Loan Bank Advances Activity For Year Maximum Daily Amount Outstanding FederalHomeLoanBankAdvancesActivityForYearMaximumDailyAmountOutstanding	196100000
CY2017	pmt	Note Payable Weighted Average Interest Rate During Period NotePayableWeightedAverageInterestRateDuringPeriod	0.0571
CY2016	pmt	Note Payable Weighted Average Interest Rate During Period NotePayableWeightedAverageInterestRateDuringPeriod	0.0473
CY2015	pmt	Note Payable Weighted Average Interest Rate During Period NotePayableWeightedAverageInterestRateDuringPeriod	0.0431
CY2017	pmt	Note Payable Average Balance During Period NotePayableAverageBalanceDuringPeriod	145638000
CY2016	pmt	Note Payable Average Balance During Period NotePayableAverageBalanceDuringPeriod	202293000
CY2015	pmt	Note Payable Average Balance During Period NotePayableAverageBalanceDuringPeriod	119307000
CY2017	pmt	Note Payable Interest Expense During Period NotePayableInterestExpenseDuringPeriod	12634000
CY2016	pmt	Note Payable Interest Expense During Period NotePayableInterestExpenseDuringPeriod	12892000
CY2015	pmt	Note Payable Interest Expense During Period NotePayableInterestExpenseDuringPeriod	6826000
CY2017Q4	pmt	Notes Payable Gross NotesPayableGross	0
CY2016Q4	pmt	Notes Payable Gross NotesPayableGross	275106000
CY2017	pmt	Note Payable Weighted Average Interest Rate NotePayableWeightedAverageInterestRate	0.00
CY2016	pmt	Note Payable Weighted Average Interest Rate NotePayableWeightedAverageInterestRate	0.0473
CY2017Q4	pmt	Mortgage Servicing Rights Secured Notes Payable MortgageServicingRightsSecuredNotesPayable	180317000
CY2016Q4	pmt	Mortgage Servicing Rights Secured Notes Payable MortgageServicingRightsSecuredNotesPayable	656567000
CY2017Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	250000000
CY2016Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	250000000
CY2015Q4	pmt	Representations And Warranties Liability RepresentationsAndWarrantiesLiability	20171000
CY2014Q4	pmt	Representations And Warranties Liability RepresentationsAndWarrantiesLiability	14242000
CY2017	pmt	Provisions For Representations And Warranties Losses ProvisionsForRepresentationsAndWarrantiesLosses	3147000
CY2016	pmt	Provisions For Representations And Warranties Losses ProvisionsForRepresentationsAndWarrantiesLosses	3254000
CY2015	pmt	Provisions For Representations And Warranties Losses ProvisionsForRepresentationsAndWarrantiesLosses	5771000
CY2017	pmt	Reduction In Liability Due To Change In Estimate ReductionInLiabilityDueToChangeInEstimate	-9679000
CY2016	pmt	Reduction In Liability Due To Change In Estimate ReductionInLiabilityDueToChangeInEstimate	-7564000
CY2015	pmt	Reduction In Liability Due To Change In Estimate ReductionInLiabilityDueToChangeInEstimate	0
CY2017	pmt	Representations And Warranties Losses Incurred RepresentationsAndWarrantiesLossesIncurred	140000
CY2016	pmt	Representations And Warranties Losses Incurred RepresentationsAndWarrantiesLossesIncurred	511000
CY2015	pmt	Representations And Warranties Losses Incurred RepresentationsAndWarrantiesLossesIncurred	176000
CY2017	pmt	Representations And Warranties Recovery RepresentationsAndWarrantiesRecovery	0
CY2016	pmt	Representations And Warranties Recovery RepresentationsAndWarrantiesRecovery	0
CY2015	pmt	Representations And Warranties Recovery RepresentationsAndWarrantiesRecovery	334000
CY2017Q4	pmt	Guarantee Obligations Recourse Provision Unpaid Principal Balance Of Mortgage Loans Subject To Representations And Warranties GuaranteeObligationsRecourseProvisionUnpaidPrincipalBalanceOfMortgageLoansSubjectToRepresentationsAndWarranties	71416333000
CY2016Q4	pmt	Guarantee Obligations Recourse Provision Unpaid Principal Balance Of Mortgage Loans Subject To Representations And Warranties GuaranteeObligationsRecourseProvisionUnpaidPrincipalBalanceOfMortgageLoansSubjectToRepresentationsAndWarranties	56114162000
CY2015Q4	pmt	Guarantee Obligations Recourse Provision Unpaid Principal Balance Of Mortgage Loans Subject To Representations And Warranties GuaranteeObligationsRecourseProvisionUnpaidPrincipalBalanceOfMortgageLoansSubjectToRepresentationsAndWarranties	41842601000
CY2017Q4	pmt	Mortgage Loans Acquired For Sale Outstanding Contractual Purchase Commitments MortgageLoansAcquiredForSaleOutstandingContractualPurchaseCommitments	1250803000
CY2017Q4	pmt	Commitments To Fund Deposits Securing Credit Risk Transfer Agreements CommitmentsToFundDepositsSecuringCreditRiskTransferAgreements	482471000
CY2017Q4	us-gaap	Preferred Stock Discount On Shares PreferredStockDiscountOnShares	10293000
CY2017	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	5647000
CY2016	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	7368000
CY2015	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	1045000
CY2017Q4	pmt	Stock Repurchase Program Cumulative Number Of Shares Repurchased StockRepurchaseProgramCumulativeNumberOfSharesRepurchased	14060000
CY2017Q4	pmt	Stock Repurchase Program Cost Of Cumulative Shares Repurchased StockRepurchaseProgramCostOfCumulativeSharesRepurchased	205906000
CY2017	pmt	Agreement Effective Date AgreementEffectiveDate	2013-02-01
CY2017	us-gaap	Payment For Incentive Fee PaymentForIncentiveFee	10
CY2017	us-gaap	Performance Fees PerformanceFees	100
CY2017	pmt	Contingent Underwriting Fee Payments To Underwriters ContingentUnderwritingFeePaymentsToUnderwriters	61000
CY2016	pmt	Contingent Underwriting Fee Payments To Underwriters ContingentUnderwritingFeePaymentsToUnderwriters	0
CY2015	pmt	Contingent Underwriting Fee Payments To Underwriters ContingentUnderwritingFeePaymentsToUnderwriters	473000
CY2017	pmt	Average Balance During Period For Servicing Assets Portfolio AverageBalanceDuringPeriodForServicingAssetsPortfolio	63836843000
CY2016	pmt	Average Balance During Period For Servicing Assets Portfolio AverageBalanceDuringPeriodForServicingAssetsPortfolio	49626758000
CY2015	pmt	Average Balance During Period For Servicing Assets Portfolio AverageBalanceDuringPeriodForServicingAssetsPortfolio	38450379000
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	765000
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	734000
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	725000
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	262000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	330000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	312000
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	284000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	299000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	302000
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	50000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	1000
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	693000
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	16.19
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	21.26
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	21.00
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	15.25
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.46
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	21.06
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	18.37
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	18.46
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	19.65
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	16.12
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	21.29
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	15.50
CY2017	pmt	Share Based Compensation Cash And Noncash Relating To Share Based Grants ShareBasedCompensationCashAndNoncashRelatingToShareBasedGrants	4904000
CY2016	pmt	Share Based Compensation Cash And Noncash Relating To Share Based Grants ShareBasedCompensationCashAndNoncashRelatingToShareBasedGrants	5748000
CY2015	pmt	Share Based Compensation Cash And Noncash Relating To Share Based Grants ShareBasedCompensationCashAndNoncashRelatingToShareBasedGrants	6346000
CY2017	pmt	Fair Value Of Vested Units During The Year FairValueOfVestedUnitsDuringTheYear	5219000
CY2016	pmt	Fair Value Of Vested Units During The Year FairValueOfVestedUnitsDuringTheYear	5510000
CY2015	pmt	Fair Value Of Vested Units During The Year FairValueOfVestedUnitsDuringTheYear	5929000
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	4269000
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	0
CY2017Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	2954000
CY2016Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	0
CY2017	pmt	Percentage Of Deduction From Taxable Income For Ordinary Reit Dividends PercentageOfDeductionFromTaxableIncomeForOrdinaryREITDividends	0.20
CY2017	pmt	Percentage Of Ordinary Income PercentageOfOrdinaryIncome	0.71
CY2016	pmt	Percentage Of Ordinary Income PercentageOfOrdinaryIncome	0.60
CY2015	pmt	Percentage Of Ordinary Income PercentageOfOrdinaryIncome	0.41
CY2017	pmt	Percentage Of Distributions Characterized As Long Term Capital Gain PercentageOfDistributionsCharacterizedAsLongTermCapitalGain	0.29
CY2016	pmt	Percentage Of Distributions Characterized As Long Term Capital Gain PercentageOfDistributionsCharacterizedAsLongTermCapitalGain	0.40
CY2015	pmt	Percentage Of Distributions Characterized As Long Term Capital Gain PercentageOfDistributionsCharacterizedAsLongTermCapitalGain	0.25
CY2017	pmt	Percentage Of Return Of Capital PercentageOfReturnOfCapital	0.00
CY2016	pmt	Percentage Of Return Of Capital PercentageOfReturnOfCapital	0.00
CY2015	pmt	Percentage Of Return Of Capital PercentageOfReturnOfCapital	0.34
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2017Q4	pmt	Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit	13000000
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	251000
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	361000
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	671000
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	57000
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	81000
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	204000
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	308000
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	442000
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	875000
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3824000
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-8790000
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-13124000
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	2665000
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-5699000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.00
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4547000
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6489000
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-14489000
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-17671000
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	43591000
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	21617000
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	25656000
CY2017	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	25754000
CY2016	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	32501000
CY2015	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	40366000
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1687000
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3652000
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2823000
CY2017	pmt	Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit	-12992000
CY2016	pmt	Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit	0
CY2015	pmt	Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit	0
CY2017	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	265000
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	489000
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	737000
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	0.207
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	0.526
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	0.551
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.014
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.059
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.039
CY2017	pmt	Tax Cuts And Jobs Act Of2017 Change In Percentage Of Tax Rate Income Tax Expense Benefit TaxCutsAndJobsActOf2017ChangeInPercentageOfTaxRateIncomeTaxExpenseBenefit	-0.104
CY2016	pmt	Tax Cuts And Jobs Act Of2017 Change In Percentage Of Tax Rate Income Tax Expense Benefit TaxCutsAndJobsActOf2017ChangeInPercentageOfTaxRateIncomeTaxExpenseBenefit	0.00
CY2015	pmt	Tax Cuts And Jobs Act Of2017 Change In Percentage Of Tax Rate Income Tax Expense Benefit TaxCutsAndJobsActOf2017ChangeInPercentageOfTaxRateIncomeTaxExpenseBenefit	0.00
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.008
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.011
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.00
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.00
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.055
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.227
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.229
CY2017	pmt	Deferred Income Tax Expense Benefit Real Estate Valuation Loss DeferredIncomeTaxExpenseBenefitRealEstateValuationLoss	-3476000
CY2016	pmt	Deferred Income Tax Expense Benefit Real Estate Valuation Loss DeferredIncomeTaxExpenseBenefitRealEstateValuationLoss	-2732000
CY2015	pmt	Deferred Income Tax Expense Benefit Real Estate Valuation Loss DeferredIncomeTaxExpenseBenefitRealEstateValuationLoss	1577000
CY2017	pmt	Deferred Income Tax Expense Benefit Mortgage Servicing Rights DeferredIncomeTaxExpenseBenefitMortgageServicingRights	-15516000
CY2016	pmt	Deferred Income Tax Expense Benefit Mortgage Servicing Rights DeferredIncomeTaxExpenseBenefitMortgageServicingRights	-10597000
CY2015	pmt	Deferred Income Tax Expense Benefit Mortgage Servicing Rights DeferredIncomeTaxExpenseBenefitMortgageServicingRights	31324000
CY2017	pmt	Deferred Income Tax Expense Benefit Of Operating Loss Carryforward DeferredIncomeTaxExpenseBenefitOfOperatingLossCarryforward	-4333000
CY2016	pmt	Deferred Income Tax Expense Benefit Of Operating Loss Carryforward DeferredIncomeTaxExpenseBenefitOfOperatingLossCarryforward	19863000
CY2015	pmt	Deferred Income Tax Expense Benefit Of Operating Loss Carryforward DeferredIncomeTaxExpenseBenefitOfOperatingLossCarryforward	-33297000
CY2017	pmt	Deferred Income Tax Expense Benefit Of Liability Losses Under Representation And Warranties DeferredIncomeTaxExpenseBenefitOfLiabilityLossesUnderRepresentationAndWarranties	-2652000
CY2016	pmt	Deferred Income Tax Expense Benefit Of Liability Losses Under Representation And Warranties DeferredIncomeTaxExpenseBenefitOfLiabilityLossesUnderRepresentationAndWarranties	-2222000
CY2015	pmt	Deferred Income Tax Expense Benefit Of Liability Losses Under Representation And Warranties DeferredIncomeTaxExpenseBenefitOfLiabilityLossesUnderRepresentationAndWarranties	2467000
CY2017	pmt	Deferred Income Tax Expense Benefit Excess Interest Expense Disallowance DeferredIncomeTaxExpenseBenefitExcessInterestExpenseDisallowance	7304000
CY2016	pmt	Deferred Income Tax Expense Benefit Excess Interest Expense Disallowance DeferredIncomeTaxExpenseBenefitExcessInterestExpenseDisallowance	8721000
CY2015	pmt	Deferred Income Tax Expense Benefit Excess Interest Expense Disallowance DeferredIncomeTaxExpenseBenefitExcessInterestExpenseDisallowance	15384000
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0
CY2017	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	808000
CY2016	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-1456000
CY2015	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-216000
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0
CY2016	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	74477000
CY2015	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	88411000
CY2017	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	8757000
CY2016	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	8719000
CY2015	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	8468000
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	110248000
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	101491000
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	74477000
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	88411000
CY2017	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	101491000
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	83196000
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	96879000
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2017Q4	pmt	Income Taxes Payable Receivable IncomeTaxesPayableReceivable	148000
CY2016Q4	pmt	Income Taxes Payable Receivable IncomeTaxesPayableReceivable	-2519000
CY2017Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	27169000
CY2016Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	20685000
CY2017Q4	pmt	Deferred Tax Assets Real Estate Valuation Loss DeferredTaxAssetsRealEstateValuationLoss	4143000
CY2016Q4	pmt	Deferred Tax Assets Real Estate Valuation Loss DeferredTaxAssetsRealEstateValuationLoss	9542000
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	39788000
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	60435000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	2416000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	6189000
CY2017Q4	pmt	Deferred Tax Assets Excess Interest Expense Disallowance DeferredTaxAssetsExcessInterestExpenseDisallowance	20135000
CY2016Q4	pmt	Deferred Tax Assets Excess Interest Expense Disallowance DeferredTaxAssetsExcessInterestExpenseDisallowance	24105000
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	848000
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1882000
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	67330000
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	102153000
CY2017Q4	us-gaap	Deferred Tax Liabilities Mortgage Servicing Rights DeferredTaxLiabilitiesMortgageServicingRights	94499000
CY2016Q4	us-gaap	Deferred Tax Liabilities Mortgage Servicing Rights DeferredTaxLiabilitiesMortgageServicingRights	122838000
CY2017Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0
CY2016Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	94499000
CY2016Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	122838000
CY2017Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	131500000
CY2016Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	152100000
CY2017	pmt	Net Operating Loss Carry Forwards Expiration Date NetOperatingLossCarryForwardsExpirationDate	2033
CY2016	pmt	Net Operating Loss Carry Forwards Expiration Date NetOperatingLossCarryForwardsExpirationDate	2036
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2017	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	991000
CY2016	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	1333000
CY2015	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	1689000
CY2015	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	423000
CY2017	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	8467000
CY2016	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	8467000
CY2015	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	8467000
CY2017	pmt	Other Operating Income Loss Net OtherOperatingIncomeLossNet	33995000
CY2017	pmt	Loan Fulfillment Servicing And Management Fees Payable To Affiliate LoanFulfillmentServicingAndManagementFeesPayableToAffiliate	123423000
CY2017	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	47387000
CY2016	pmt	Other Operating Income Loss Net OtherOperatingIncomeLossNet	31328000
CY2016	pmt	Loan Fulfillment Servicing And Management Fees Payable To Affiliate LoanFulfillmentServicingAndManagementFeesPayableToAffiliate	137080000
CY2016	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	52588000
CY2015	pmt	Other Operating Income Loss Net OtherOperatingIncomeLossNet	17808000
CY2015	pmt	Loan Fulfillment Servicing And Management Fees Payable To Affiliate LoanFulfillmentServicingAndManagementFeesPayableToAffiliate	105030000
CY2015	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	46237000
CY2015Q4	us-gaap	Assets Assets	5826924000
CY2017Q4	us-gaap	Revenues Revenues	93703000
CY2017Q3	us-gaap	Revenues Revenues	75804000
CY2017Q2	us-gaap	Revenues Revenues	83959000
CY2017Q1	us-gaap	Revenues Revenues	64474000
CY2016Q4	us-gaap	Revenues Revenues	68928000
CY2016Q3	us-gaap	Revenues Revenues	103326000
CY2016Q2	us-gaap	Revenues Revenues	47618000
CY2016Q1	us-gaap	Revenues Revenues	52216000
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	40838000
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	19395000
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	28780000
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	28737000
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	31174000
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	35408000
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-5267000
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	14496000
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.53
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.39
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.46
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.50
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.44
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2017Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.47
CY2017Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.47
CY2017Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.47
CY2017Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.47
CY2016Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.47
CY2016Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.47
CY2016Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.47
CY2016Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.47
CY2017Q3	us-gaap	Short Term Investments ShortTermInvestments	5646000
CY2017Q2	us-gaap	Short Term Investments ShortTermInvestments	77366000
CY2017Q1	us-gaap	Short Term Investments ShortTermInvestments	19883000
CY2016Q3	us-gaap	Short Term Investments ShortTermInvestments	33353000
CY2016Q2	us-gaap	Short Term Investments ShortTermInvestments	16877000
CY2016Q1	us-gaap	Short Term Investments ShortTermInvestments	47500000
CY2017Q3	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	1036669000
CY2017Q2	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	1065540000
CY2017Q1	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	1089610000
CY2016Q3	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	708862000
CY2017Q3	pmt	Selected Quarterly Results Other Assets SelectedQuarterlyResultsOtherAssets	857767000
CY2017Q2	pmt	Selected Quarterly Results Other Assets SelectedQuarterlyResultsOtherAssets	776977000
CY2017Q1	pmt	Selected Quarterly Results Other Assets SelectedQuarterlyResultsOtherAssets	796834000
CY2016Q1	us-gaap	Assets Assets	5820440000
CY2017Q4	pmt	Assets Sold Under Agreements To Repurchase Repurchase Liability And Participating Mortgage Loans Participation Liabilities Amount AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiabilityAndParticipatingMortgageLoansParticipationLiabilitiesAmount	3225374000
CY2016Q4	pmt	Mortgage Servicing Rights MortgageServicingRights	656567000
CY2016Q3	pmt	Mortgage Servicing Rights MortgageServicingRights	524529000
CY2016Q2	pmt	Mortgage Servicing Rights MortgageServicingRights	471458000
CY2016Q1	pmt	Mortgage Servicing Rights MortgageServicingRights	455097000
CY2017Q4	pmt	Selected Quarterly Results Other Assets SelectedQuarterlyResultsOtherAssets	949682000
CY2016Q2	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	531612000
CY2016Q1	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	364439000
CY2017Q4	pmt	Selected Quarterly Results Mortgage Loans On Real Estate SelectedQuarterlyResultsMortgageLoansOnRealEstate	2358988000
CY2017Q3	pmt	Selected Quarterly Results Mortgage Loans On Real Estate SelectedQuarterlyResultsMortgageLoansOnRealEstate	2618283000
CY2017Q2	pmt	Selected Quarterly Results Mortgage Loans On Real Estate SelectedQuarterlyResultsMortgageLoansOnRealEstate	2846415000
CY2017Q1	pmt	Selected Quarterly Results Mortgage Loans On Real Estate SelectedQuarterlyResultsMortgageLoansOnRealEstate	2861797000
CY2016Q4	pmt	Selected Quarterly Results Mortgage Loans On Real Estate SelectedQuarterlyResultsMortgageLoansOnRealEstate	3394853000
CY2016Q3	pmt	Selected Quarterly Results Mortgage Loans On Real Estate SelectedQuarterlyResultsMortgageLoansOnRealEstate	4000570000
CY2016Q2	pmt	Selected Quarterly Results Mortgage Loans On Real Estate SelectedQuarterlyResultsMortgageLoansOnRealEstate	3497026000
CY2016Q1	pmt	Selected Quarterly Results Mortgage Loans On Real Estate SelectedQuarterlyResultsMortgageLoansOnRealEstate	3836411000
CY2017Q3	pmt	Excess Spread Investment ExcessSpreadInvestment	248763000
CY2017Q2	pmt	Excess Spread Investment ExcessSpreadInvestment	261796000
CY2017Q1	pmt	Excess Spread Investment ExcessSpreadInvestment	277484000
CY2016Q3	pmt	Excess Spread Investment ExcessSpreadInvestment	280367000
CY2016Q2	pmt	Excess Spread Investment ExcessSpreadInvestment	294551000
CY2016Q1	pmt	Excess Spread Investment ExcessSpreadInvestment	321976000
CY2017Q4	pmt	Real Estate Acquired In Settlement Of Loans And Real Estate Held For Investment RealEstateAcquiredInSettlementOfLoansAndRealEstateHeldForInvestment	207089000
CY2017Q3	pmt	Real Estate Acquired In Settlement Of Loans And Real Estate Held For Investment RealEstateAcquiredInSettlementOfLoansAndRealEstateHeldForInvestment	227580000
CY2017Q2	pmt	Real Estate Acquired In Settlement Of Loans And Real Estate Held For Investment RealEstateAcquiredInSettlementOfLoansAndRealEstateHeldForInvestment	247350000
CY2017Q1	pmt	Real Estate Acquired In Settlement Of Loans And Real Estate Held For Investment RealEstateAcquiredInSettlementOfLoansAndRealEstateHeldForInvestment	260368000
CY2016Q4	pmt	Real Estate Acquired In Settlement Of Loans And Real Estate Held For Investment RealEstateAcquiredInSettlementOfLoansAndRealEstateHeldForInvestment	303393000
CY2016Q3	pmt	Real Estate Acquired In Settlement Of Loans And Real Estate Held For Investment RealEstateAcquiredInSettlementOfLoansAndRealEstateHeldForInvestment	314056000
CY2016Q2	pmt	Real Estate Acquired In Settlement Of Loans And Real Estate Held For Investment RealEstateAcquiredInSettlementOfLoansAndRealEstateHeldForInvestment	320120000
CY2016Q1	pmt	Real Estate Acquired In Settlement Of Loans And Real Estate Held For Investment RealEstateAcquiredInSettlementOfLoansAndRealEstateHeldForInvestment	339970000
CY2017Q4	pmt	Mortgage Servicing Rights MortgageServicingRights	844781000
CY2017Q3	pmt	Mortgage Servicing Rights MortgageServicingRights	790335000
CY2017Q2	pmt	Mortgage Servicing Rights MortgageServicingRights	734800000
CY2017Q1	pmt	Mortgage Servicing Rights MortgageServicingRights	696970000
CY2016Q4	pmt	Selected Quarterly Results Other Assets SelectedQuarterlyResultsOtherAssets	726871000
CY2016Q3	pmt	Selected Quarterly Results Other Assets SelectedQuarterlyResultsOtherAssets	757164000
CY2016Q2	pmt	Selected Quarterly Results Other Assets SelectedQuarterlyResultsOtherAssets	635918000
CY2016Q1	pmt	Selected Quarterly Results Other Assets SelectedQuarterlyResultsOtherAssets	455047000
CY2017Q3	us-gaap	Assets Assets	5785043000
CY2017Q2	us-gaap	Assets Assets	6010244000
CY2017Q1	us-gaap	Assets Assets	6002946000
CY2016Q3	us-gaap	Assets Assets	6618901000
CY2016Q2	us-gaap	Assets Assets	5767562000
CY2017Q3	pmt	Assets Sold Under Agreements To Repurchase Repurchase Liability And Participating Mortgage Loans Participation Liabilities Amount AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiabilityAndParticipatingMortgageLoansParticipationLiabilitiesAmount	3247374000
CY2017Q2	pmt	Assets Sold Under Agreements To Repurchase Repurchase Liability And Participating Mortgage Loans Participation Liabilities Amount AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiabilityAndParticipatingMortgageLoansParticipationLiabilitiesAmount	3536344000
CY2017Q1	pmt	Assets Sold Under Agreements To Repurchase Repurchase Liability And Participating Mortgage Loans Participation Liabilities Amount AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiabilityAndParticipatingMortgageLoansParticipationLiabilitiesAmount	3573165000
CY2016Q4	pmt	Assets Sold Under Agreements To Repurchase Repurchase Liability And Participating Mortgage Loans Participation Liabilities Amount AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiabilityAndParticipatingMortgageLoansParticipationLiabilitiesAmount	3809918000
CY2016Q3	pmt	Assets Sold Under Agreements To Repurchase Repurchase Liability And Participating Mortgage Loans Participation Liabilities Amount AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiabilityAndParticipatingMortgageLoansParticipationLiabilitiesAmount	4129543000
CY2016Q2	pmt	Assets Sold Under Agreements To Repurchase Repurchase Liability And Participating Mortgage Loans Participation Liabilities Amount AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiabilityAndParticipatingMortgageLoansParticipationLiabilitiesAmount	3372026000
CY2016Q1	pmt	Assets Sold Under Agreements To Repurchase Repurchase Liability And Participating Mortgage Loans Participation Liabilities Amount AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiabilityAndParticipatingMortgageLoansParticipationLiabilitiesAmount	3307414000
CY2017Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	144128000
CY2017Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	228178000
CY2017Q2	us-gaap	Notes And Loans Payable NotesAndLoansPayable	309980000
CY2017Q1	us-gaap	Notes And Loans Payable NotesAndLoansPayable	250088000
CY2016Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	425106000
CY2016Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	346132000
CY2016Q2	us-gaap	Notes And Loans Payable NotesAndLoansPayable	313976000
CY2016Q1	us-gaap	Notes And Loans Payable NotesAndLoansPayable	356191000
CY2017Q3	pmt	Asset Backed Secured Financing Liability Fair Value AssetBackedSecuredFinancingLiabilityFairValue	318404000
CY2017Q2	pmt	Asset Backed Secured Financing Liability Fair Value AssetBackedSecuredFinancingLiabilityFairValue	329459000
CY2017Q1	pmt	Asset Backed Secured Financing Liability Fair Value AssetBackedSecuredFinancingLiabilityFairValue	340365000
CY2016Q3	pmt	Asset Backed Secured Financing Liability Fair Value AssetBackedSecuredFinancingLiabilityFairValue	384407000
CY2016Q2	pmt	Asset Backed Secured Financing Liability Fair Value AssetBackedSecuredFinancingLiabilityFairValue	325939000
CY2016Q1	pmt	Asset Backed Secured Financing Liability Fair Value AssetBackedSecuredFinancingLiabilityFairValue	344693000
CY2017Q3	us-gaap	Convertible Debt ConvertibleDebt	246906000
CY2017Q2	us-gaap	Convertible Debt ConvertibleDebt	246629000
CY2017Q1	us-gaap	Convertible Debt ConvertibleDebt	246357000
CY2016Q3	us-gaap	Convertible Debt ConvertibleDebt	245824000
CY2016Q2	us-gaap	Convertible Debt ConvertibleDebt	245564000
CY2016Q1	us-gaap	Convertible Debt ConvertibleDebt	245307000
CY2017Q4	us-gaap	Other Liabilities OtherLiabilities	136241000
CY2017Q3	us-gaap	Other Liabilities OtherLiabilities	133616000
CY2017Q2	us-gaap	Other Liabilities OtherLiabilities	133000000
CY2017Q1	us-gaap	Other Liabilities OtherLiabilities	134381000
CY2016Q4	us-gaap	Other Liabilities OtherLiabilities	171377000
CY2016Q3	us-gaap	Other Liabilities OtherLiabilities	158077000
CY2016Q2	us-gaap	Other Liabilities OtherLiabilities	149230000
CY2016Q1	us-gaap	Other Liabilities OtherLiabilities	152332000
CY2017Q3	us-gaap	Liabilities Liabilities	4174478000
CY2017Q2	us-gaap	Liabilities Liabilities	4555412000
CY2017Q1	us-gaap	Liabilities Liabilities	4544356000
CY2016Q3	us-gaap	Liabilities Liabilities	5263983000
CY2016Q2	us-gaap	Liabilities Liabilities	4406735000
CY2016Q1	us-gaap	Liabilities Liabilities	4405937000
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	1610565000
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	1454832000
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	1458590000
CY2016Q3	us-gaap	Stockholders Equity StockholdersEquity	1354918000
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	1360827000
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	1414503000
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5785043000
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6010244000
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6002946000
CY2016Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6618901000
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5767562000
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5820440000
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-2354000
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1294000
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1116000
CY2017	us-gaap	Interest Paid InterestPaid	152441000
CY2016	us-gaap	Interest Paid InterestPaid	157686000
CY2015	us-gaap	Interest Paid InterestPaid	117223000
CY2017	pmt	Receipt Of Mortgage Servicing Rights As Proceeds From Sales Of Loans ReceiptOfMortgageServicingRightsAsProceedsFromSalesOfLoans	290309000
CY2016	pmt	Receipt Of Mortgage Servicing Rights As Proceeds From Sales Of Loans ReceiptOfMortgageServicingRightsAsProceedsFromSalesOfLoans	275092000
CY2015	pmt	Receipt Of Mortgage Servicing Rights As Proceeds From Sales Of Loans ReceiptOfMortgageServicingRightsAsProceedsFromSalesOfLoans	154474000
CY2017	pmt	Increase Decrease Of Excess Servicing Spread Recapture Receivable From Affiliates IncreaseDecreaseOfExcessServicingSpreadRecaptureReceivableFromAffiliates	5244000
CY2016	pmt	Increase Decrease Of Excess Servicing Spread Recapture Receivable From Affiliates IncreaseDecreaseOfExcessServicingSpreadRecaptureReceivableFromAffiliates	6603000
CY2015	pmt	Increase Decrease Of Excess Servicing Spread Recapture Receivable From Affiliates IncreaseDecreaseOfExcessServicingSpreadRecaptureReceivableFromAffiliates	6728000
CY2017	pmt	Capitalization Of Servicing Advances Pursuant To Mortgage Loan Modifications CapitalizationOfServicingAdvancesPursuantToMortgageLoanModifications	18923000
CY2016	pmt	Capitalization Of Servicing Advances Pursuant To Mortgage Loan Modifications CapitalizationOfServicingAdvancesPursuantToMortgageLoanModifications	0
CY2015	pmt	Capitalization Of Servicing Advances Pursuant To Mortgage Loan Modifications CapitalizationOfServicingAdvancesPursuantToMortgageLoanModifications	0
CY2017	pmt	Transfer Of Mortgage Loans Acquired For Sale To Mortgage Loans At Fair Value TransferOfMortgageLoansAcquiredForSaleToMortgageLoansAtFairValue	0
CY2016	pmt	Transfer Of Mortgage Loans Acquired For Sale To Mortgage Loans At Fair Value TransferOfMortgageLoansAcquiredForSaleToMortgageLoansAtFairValue	0
CY2015	pmt	Transfer Of Mortgage Loans Acquired For Sale To Mortgage Loans At Fair Value TransferOfMortgageLoansAcquiredForSaleToMortgageLoansAtFairValue	23859000
CY2017Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	29145000
CY2016Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	31655000
CY2015Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	35069000
CY2017	pmt	Transfer Mortgage Loans Financed To Reo Financed TransferMortgageLoansFinancedToReoFinanced	0
CY2016	pmt	Transfer Mortgage Loans Financed To Reo Financed TransferMortgageLoansFinancedToReoFinanced	0
CY2015	pmt	Transfer Mortgage Loans Financed To Reo Financed TransferMortgageLoansFinancedToReoFinanced	85134000
CY2017Q4	us-gaap	Minimum Net Worth Required For Compliance MinimumNetWorthRequiredForCompliance	2500000
CY2017Q4	us-gaap	Loans Receivable Basis Spread On Variable Rate LoansReceivableBasisSpreadOnVariableRate	0.0025
CY2017	pmt	Number Of Residential Mortgage Loans Served NumberOfResidentialMortgageLoansServed	1-4

Files In Submission

Name	View Source	Status
0001564590-18-004038-index-headers.html	Edgar Link	pending
0001564590-18-004038-index.html	Edgar Link	pending
0001564590-18-004038.txt	Edgar Link	pending
0001564590-18-004038-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pmt-10k_20171231.htm	Edgar Link	pending
pmt-20171231.xml	Edgar Link	completed
pmt-20171231.xsd	Edgar Link	pending
pmt-20171231_cal.xml	Edgar Link	unprocessable
pmt-20171231_def.xml	Edgar Link	unprocessable
pmt-20171231_lab.xml	Edgar Link	unprocessable
pmt-20171231_pre.xml	Edgar Link	unprocessable
pmt-ex10103_107.htm	Edgar Link	pending
pmt-ex10106_105.htm	Edgar Link	pending
pmt-ex10115_115.htm	Edgar Link	pending
pmt-ex1012_112.htm	Edgar Link	pending
pmt-ex1014_111.htm	Edgar Link	pending
pmt-ex1019_280.htm	Edgar Link	pending
pmt-ex1023_113.htm	Edgar Link	pending
pmt-ex1029_110.htm	Edgar Link	pending
pmt-ex1090_109.htm	Edgar Link	pending
pmt-ex1096_108.htm	Edgar Link	pending
pmt-ex211_13.htm	Edgar Link	pending
pmt-ex231_6.htm	Edgar Link	pending
pmt-ex311_24.htm	Edgar Link	pending
pmt-ex312_8.htm	Edgar Link	pending
pmt-ex321_21.htm	Edgar Link	pending
pmt-ex322_23.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R132.htm	Edgar Link	pending
R133.htm	Edgar Link	pending
R134.htm	Edgar Link	pending
R135.htm	Edgar Link	pending
R136.htm	Edgar Link	pending
R137.htm	Edgar Link	pending
R138.htm	Edgar Link	pending
R139.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R140.htm	Edgar Link	pending
R141.htm	Edgar Link	pending
R142.htm	Edgar Link	pending
R143.htm	Edgar Link	pending
R144.htm	Edgar Link	pending
R145.htm	Edgar Link	pending
R146.htm	Edgar Link	pending
R147.htm	Edgar Link	pending
R148.htm	Edgar Link	pending
R149.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R150.htm	Edgar Link	pending
R151.htm	Edgar Link	pending
R152.htm	Edgar Link	pending
R153.htm	Edgar Link	pending
R154.htm	Edgar Link	pending
R155.htm	Edgar Link	pending
R156.htm	Edgar Link	pending
R157.htm	Edgar Link	pending
R158.htm	Edgar Link	pending
R159.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R160.htm	Edgar Link	pending
R161.htm	Edgar Link	pending
R162.htm	Edgar Link	pending
R163.htm	Edgar Link	pending
R164.htm	Edgar Link	pending
R165.htm	Edgar Link	pending
R166.htm	Edgar Link	pending
R167.htm	Edgar Link	pending
R168.htm	Edgar Link	pending
R169.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R170.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PMT
PennyMac Mortgage Investment Trust Stock $pmt

2017 Q4 Form 10-K Financial Statement

#000156459018004038 Filed on March 01, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMT PennyMac Mortgage Investment Trust Stock $pmt

2017 Q4 Form 10-K Financial Statement

#000156459018004038 Filed on March 01, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMT
PennyMac Mortgage Investment Trust Stock $pmt